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Executive summary 
 
Background and rationale for focusing on cocaine-related emergencies 
 
The use and seizures of cocaine have increased during the last decade, particularly in some 
countries, and cocaine is now the second most used illicit drug in Europe, after cannabis. However, 
levels of use differ widely between countries, and there is a noticeable diversity among cocaine 
users, both in patterns of use and sociodemographic characteristics, which complicate an 
assessment of the prevalence of the drug’s use, its health and social consequences, and the 
necessary responses. 
 
Cocaine-related health consequences are difficult to observe. This is partly due to the often 
unspecific or chronic nature of the pathologies typically arising from the long-term use of cocaine, 
and also to the difficulties in establishing causal links between illness and the use of the drug. Data 
on market indicators (e.g. seizures) and prevalence of use can help to approximate the extent of 
cocaine use and availability at a European level, but the traditional indicators of drug problems 
(e.g. treatment demand or drug-related deaths) may not identify many of the health consequences 
of use. Data from drug users attending hospital emergency departments (and other health 
emergency services) may be a useful source of information on the consequences of drug use that 
are not recorded elsewhere, and can also capture new or emerging drug-related problems.  
 
In the United States, data on drug-related hospital emergencies from the Drug Abuse Warning 
Network (DAWN) system are widely used to help monitor problems related to drug use in general, 
including cocaine. In Europe, however, although some information on drug-related hospital 
emergencies is available from several countries, it has not been systematically collated. 
 
Objectives  
 
This publication completes and expands on the paper in European Addiction Research by Mena et 
al. (2013) on cocaine-related health emergencies in Europe. Its objectives are:  
 
 
• To present a summarised literature review of the most common health problems caused by 
cocaine use, focused on cardiovascular, cerebrovascular and neurological problems. 
 
• To describe the sources of information on drug- and cocaine-related health emergencies in 
Europe and analyse relevant data from European countries’ recent annual National reports 
to the EMCDDA. 
 
• To discuss the limitations of the data collected on cocaine-related acute emergencies and 
the public health implications of the cocaine-related results. 
 
• To discuss the broader issue of using data from emergency settings to help monitor 
problems related to drug use. 
 
Methods  
 
A review of the literature on cocaine-related health consequences was conducted by the EMCDDA 
focused on the topics mentioned above. Information on hospitals’ data collection on cocaine-
related health emergencies was requested from drug-related death (DRD) experts in 30 countries 
(the 28 EU Member States, Turkey and Norway). Relevant information in each country’s focal point 
annual report to the EMCDDA from 2007–11 (published in 2008–12) was used to expand on the 
DRD experts’ responses. Where available, statistics reported by the national focal points to the 
EMCDDA on cocaine-related cases in hospital emergency departments or other settings from 
  
5
1999–2011 were used to identify long-term trends. Data on drug-related visits to hospital 
emergency departments were obtained from 19 countries. 
 
 
Results  
 
The literature review revealed a wide range of consequences of cocaine use, including mainly 
cardiovascular, cerebrovascular and neurological complications. It was found that cocaine–alcohol 
and cocaine–heroin combinations might present particularly severe health risks compared to the 
health risk of cocaine taken alone. 
 
Data on cocaine-related emergencies were obtained from 17 of the 19 countries for which data on 
drug-related visits to hospital emergency departments were obtained (these data were not reported 
from Estonia and Malta), although they are sparse in some cases. In the most recent year for 
which data were available, the United Kingdom reported the highest number of cocaine-related 
emergency episodes (4 209 and 2 247 according to two sources, 2010–11 data), followed by Spain 
(2 386) in 2011, Italy (2 408) in 2008 and the Netherlands (an estimated 1 176 cases annually on 
average) from 2006–10. The cases are mainly male adults in their thirties, and many had used 
other drugs together with cocaine. Where information is available, most cases are related to acute 
intoxication. There has been a large (two- to three-fold) increase in the number of cocaine-related 
episodes reported from these countries since the end of the 1990s, although these increases 
peaked in Spain and England in 2007–08. 
 
Data on drug-related road traffic accidents are reported in only some countries’ National reports 
and are usually sparse. Where available, the data on the type of substances involved show that 
alcohol is by far the most common psychoactive substance involved, frequently followed by 
psychoactive medicines. Cocaine is rarely specifically mentioned, but may be included in a broader 
category such as ‘stimulant drugs’. 
 
Limitations  
 
There are limitations to the data currently available on illicit drug- and cocaine-related emergencies 
in Europe, and analysis must be conducted with caution. The countries’ approaches to recording 
and reporting emergencies vary, however, with formal indicators established only in Spain and the 
Netherlands. In some countries the data provided from a specific source are not updated the 
following year in the National reports (in Belgium and in Italy, for instance). Some of the data from 
some countries are based on local or sentinel monitoring systems, which are valuable in providing 
information on trends (when based on stable data collection) but which do not provide a complete 
account of the numbers. 
 
The picture provided here is therefore incomplete and underestimates the actual extent of cocaine-
related problems, particularly because of the absence or limitation of data from some countries 
with a known relatively high prevalence of use. Nonetheless, we believe that we have captured 
data from most of the countries that bear the largest burden of cocaine-related emergency cases. 
 
Conclusions  
 
This study reveals the substantial levels of morbidity related to cocaine use, translated into the 
large number of cocaine cases seen in various emergency settings in European countries. This 
health burden is often not captured by other traditional drug indicators. The report also points to the 
potential for early prevention, assessment and referral opportunities that may currently be 
overlooked, including the referral of some patients who may benefit from specific counselling or 
treatment.  
 
In varying degrees, many European countries are able to monitor the morbidity associated with 
drug use (including the harms related to cocaine) using data from hospitals, particularly emergency 
departments, as well as from other emergency settings, but the absence of a coherent European-
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wide monitoring system means the overall picture is difficult to determine. Although the 
implementation of such a system for monitoring drug-related emergencies has both practical and 
cost implications, our findings suggest that it would constitute an important indirect indicator of 
several aspects of drug use. Investment in this area could, for example, provide an indicator of 
drug use trends, help to monitor the consequences of drug use within Europe — in particular new 
psychoactive drugs, prescription drugs and polydrug use — and measure hospital emergency 
departments’ drug-related workload.  
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1. Introduction 
 
Cocaine: the second most commonly used illicit substance in Europe 
 
Across Europe, cocaine is the second most commonly used illicit substance among the general 
population (after cannabis). More than 14.5 million Europeans (4.2 % of 15- to 64-year-olds) are 
reported to have used cocaine at least once in their life, and 3.5 million are estimated to have done 
so in the last year (1.0 % on average: recent national surveys report last year prevalence estimates 
of between 0.1 % and 2.3 %). Cocaine use is particularly high among young adults (aged 15–34), 
with their last year prevalence reported to be 1.9 % on average and up to 3.6 % in Spain and 4.2 % 
in the United Kingdom (England and Wales) (EMCDDA, 2012a; 2013a; 2013b) 
 
Some countries (including Spain, the Netherlands and the United Kingdom) have a long-
established cocaine problem, while others (including France and Italy) have seen a rapid increase 
in use or seizures of the drug until recent years. In 2011, the largest quantities of cocaine seized 
were reported in Spain, France, the Netherlands and Belgium. Other countries, mainly in eastern 
and northern Europe (including Latvia, Lithuania and Finland), report very low figures for both 
cocaine use and seizures (EMCDDA, 2010, 2012a, 2013b). 
 
A wide range of health consequences associated with cocaine use 
 
Cocaine dependence, a chronic, relapsing and multifactor disorder, is a significant public health 
problem with somatic, legal, social, cognitive and psychological complications. The most frequent 
acute health problems associated with cocaine include neurological impairments and 
cardiovascular and cerebrovascular effects (Egred and Davis, 2005). Regular use (by any route of 
administration) can also be associated with the risk of accidents and of the transmission of 
infectious diseases through unprotected sex (Brugal et al., 2009). Recently, concerns have also 
been raised regarding the association between cocaine use and violent crimes in the night-time 
economy (Measham and Moore, 2009). In addition, cocaine users have an increased mortality 
compared with the general population (Degenhardt et al., 2011; Pavarin et al., 2011; Sanchez et 
al., 1995). Cocaine was cited as the principal reason for entering treatment by about 14 % of all 
drug treatment clients in 2011, corresponding to about 60 000 cases according to treatment 
demand indicator (TDI) data (EMCDDA, 2012a, 2013b). 
 
A health burden that is probably underestimated, and insufficiently captured by classical 
indicators 
 
Overall, there are indications of a significant health burden related to cocaine use in Europe, 
particularly in some countries, which is not yet fully identified or recognised. This is due partly to 
the often unspecific or chronic nature of the pathologies typically arising from the long-term use of 
cocaine, and also to the difficulties in establishing causal links between an illness and the use of 
the drug. In addition, urine screens of emergency department patients and referrals to addiction 
services are infrequent (de Millas et al., 2010). These issues, along with countries’ differing data 
collection systems for both mortality and morbidity, suggest that the currently available information 
does not fully capture the whole picture of cocaine-related health consequences. 
 
Traditional indicators of drug problems (e.g. treatment demand or drug-related deaths) may not 
identify many of the health consequences of use. Data from drug users attending hospital 
emergency departments (and other health emergency services) may be a useful source of 
information on the consequences of drug use that is not well recorded elsewhere. 
 
This publication completes and updates the paper in European Addiction Research by Mena et al. 
(2012), which reviews the sources of information on cocaine-related health emergencies in Europe. 
It contains a more in-depth literature review on the cocaine health consequences that are analysed 
and gives a broader insight into drug-related emergencies in general. It also provides information 
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on more countries and further explores the limitations of the data currently available and the public 
health implications of cocaine-related harms. This publication therefore constitutes one of the 
bases for the EMCDDA to build on its strategy to explore the feasibility of enhancing the use of 
hospital emergency data as an information source on the health consequences of drug use and to 
reflect on the possible synergies with EU-funded projects in this area. 
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2. Methods 
 
The following strategies were used to collect data for this publication: 
 
• An initial literature review on the health consequences of cocaine use, conducted for the 
EMCDDA in 2007, was updated by conducting a search using the PubMed database (1). 
This review focused only on cardiovascular, cerebrovascular and neurological problems 
and did not explore other domains, such as psychiatric problems related to cocaine. 
 
• In 2009 the EMCDDA asked experts on the key epidemiological indicator drug-related 
deaths (DRD) (2) from 30 countries (the 28 EU Member States, Turkey and Norway) about 
their countries’ system of collecting data on drug- and cocaine-related emergencies from 
various emergency settings, primarily hospital emergency departments but also 
emergencies reported through poison centres or through other emergency settings such as 
ambulance or first aid services at festivals and public events. This excluded cocaine-related 
non-acute harms. The experts were also asked for citations of any research studies on this 
issue.  
 
• Data on the health consequences related to drug use are acquired annually by the 
EMCDDA from the 30 countries’ national focal points and presented in their National 
reports (3) on the drug situation. Information on illicit drug-related emergencies in these 
reports for the period 2007–11 (published in 2008–12) was analysed, with particular 
attention given to data sources, cocaine-related emergencies, case definition, coverage 
and case characteristics. Where available, data on cocaine-related cases of road traffic 
accidents in hospital emergency departments from the 2011 National reports were included 
in the analysis. 
 
• Where available, statistics reported by the national focal points to the EMCDDA on 
cocaine-related cases in hospital emergency departments or other settings from 1999–
2011 were used to identify long-term trends. 
 
What this report does not cover: 
 
This report covers only cocaine-related acute incidents and emergency episodes. It does not cover 
the final outcome of these acute emergency episodes, such as full recovery, sequelae or death. 
Monitoring data on cocaine-related deaths in particular requires the use of other sources such as 
mortality registries (Corkery, 2012). It also requires the use of other study designs such as cohort 
studies among cocaine users or follow-up studies of the patients seen at emergency departments 
or in treatment (Degenhardt et al., 2011; Barrio et al., 2013). The present report does not aim to 
compare the burden of cocaine-related emergency to the burden associated with other drugs, such 
as heroin, amphetamines or misused medicine. In particular, alcohol-related emergencies, which 
are known to outnumber emergencies related to any other drug, are not covered. 
 
                                               
(1) The terms used in the search were: cocaine AND health AND consequences, cocaine AND acute AND 
consequences, cocaine AND chronic AND consequences, cocaine AND health AND problems, cocaine AND 
emergencies, cocaine AND casualties, cocaine AND vascular, cocaine AND complications, cocaine AND heroin, cocaine 
AND alcohol. 
(2) The EMCDDA uses five key epidemiological indicators to achieve its goal of providing factual, objective, reliable and 
comparable information on drugs and drug addiction at the European level to inform the policy debate. More information 
is available from www.emcdda.europa.eu/activities/key-indicators. National experts are nominated by the Reitox national 
focal points (www.emcdda.europa.eu/publications/brochures/rtxfaq). The EMCDDA DRD network includes pathologists, 
toxicologists, public health practitioners and epidemiologists. 
(3) National reports are available at 
www.emcdda.europa.eu/publications/searchresults?action=list&type=PUBLICATIONS&SERIES_PUB=w203. 
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3. The medical complications of cocaine use  
 
This section presents the results of the literature review on the health consequences of cocaine 
use. It focuses on some common problems: cardiovascular disorders, cerebrovascular disorders 
and neurological impairments, the consequences of combining cocaine and alcohol and of 
combining cocaine and heroin. 
 
Two broad groups of regular cocaine users can be distinguished. The first is made up of socially 
integrated users, who tend to use cocaine at weekends, at parties or on other special occasions, 
sometimes in large amounts. Many of these users report controlling their cocaine use by setting 
rules about, for example, the amount, frequency or context of use. The second group is composed 
of intensive cocaine and crack users belonging to more socially marginalised or disadvantaged 
groups. This group includes former or current opioid users who use (including by injection) cocaine 
powder and/or crack.  
 
The risks associated with certain problematic modes of cocaine use are well known and mostly 
affect specific groups of users (former or current opioid users and marginalised populations). For 
example, injecting cocaine use is associated with the risk of blood-borne viruses infection (hepatitis 
C virus (HCV) and human immunodeficiency virus (HIV)) and an elevated risk of overdose, while 
use in combination with opioids appears to be linked to a higher risk of opioid overdose (EMCDDA, 
2007).  
 
Cocaine use has been associated with a variety of medical complications, which may involve all of 
the body’s major organs or systems (Dinis-Oliveira et al., 2012). Such complications can be 
associated with acute and chronic use and may differ according to the route of administration. 
Polydrug use, involving mainly cocaine combined with heroin, alcohol and/or cannabis, is the 
predominant pattern of cocaine use in Europe. This, together with the various impurities and 
cutting agents often found in ‘street’ cocaine, may increase the adverse health effects (EMCDDA, 
2007, 2011).  
 
Acute and chronic cocaine use can cause: 
 
• cardiovascular disorders (ischaemia, acute coronary syndrome, arrhythmias, etc.); 
• cerebrovascular disorders and neurological impairment (cerebrovascular accident or stroke, 
and status epilepticus); 
• psychiatric disorders (euphoria, dysphoria, agitation, anxiety, suicidal thoughts, paranoid 
psychosis and depression); 
• respiratory disorders, either acute (pulmonary oedema, pulmonary infarction, haemoptysis) 
or chronic (e.g. pulmonary hypertension); 
• genitourinary and obstetric disorders, either acute (acute renal failure, mediated by 
rhabdomyolysis or direct toxicity, testicular infarction, placental abruption, spontaneous 
abortion) or chronic (premature birth, growth retardation); 
• gastrointestinal complications (mesenteric ischaemia or infarction); 
• musculoskeletal and dermatological disorders. 
 
Dependence is also one of the negative consequences of cocaine use. A study conducted in the 
US showed that about 5 % of cocaine users can become dependent in the first year of use, 
although not more than around 20 % of users developed dependence in the long term (Wagner 
and Anthony, 2002). Among those who become dependent, almost 40 % recover without treatment 
(Cunningham, 2000). There is also evidence that many cocaine users control their use of the drug 
by setting rules about, for example, the amount used and the frequency and context of use 
(Decorte, 2001). Daily cocaine consumption, unstable living conditions and low social support were 
variables highly associated with psychiatric morbidity in a study conducted in Spain among 705 
current regular cocaine users aged 18–30. During the last 12 months, 22 % of this sample had 
depression and specific phobia (Tortajada et al., 2012). 
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The most common adverse health consequences of cocaine use are cardiovascular disorders, 
cerebrovascular disorders and neurological impairments, which may be associated with both acute 
and chronic cocaine use (Egred and Davis, 2005). A recent study in Spain among 720 regular 
cocaine users aged 18–20 who were not regular heroin users found that 27 % had experienced 
acute cocaine intoxication during the last year. Of these, 35 % presented symptoms of psychosis 
(hallucinations or delirium) and more than 50 % reported chest pain (Santos et al., 2012). Cocaine 
injection and crack cocaine use are associated with the highest health risks, including 
cardiovascular and mental health problems.  
 
These medical consequences of cocaine use — cardiovascular disorders, cerebrovascular 
disorders and neurological impairments — are discussed in further detail below, followed by an 
examination of the effects of using a combination of cocaine and alcohol, and of cocaine and 
heroin. 
 
3.1 Cardiovascular disorders 
 
Although most cases of cocaine-associated chest pain are non-ischaemic (not related to coronary 
artery disease), myocardial infarction (a heart attack) remains the most frequently reported cardiac 
complication of cocaine use. Regular, occasional, heavy and long-term cocaine use have all been 
implicated as a trigger of non-ischaemic acute myocardial infarction (Mouhaffel et al., 1995).  
 
Atherosclerosis (accumulation of fatty materials along the walls of arteries which may eventually 
block the arteries) has also been linked to chronic cocaine use. Cocaine directly induces structural 
defects in the vascular endothelial cell barrier, which subsequently increases permeability to 
peroxidase and low-density lipoproteins (Brownlow and Pappachan, 2002). Coronary 
atherosclerosis increases the risk of myocardial infarction by as much as 24 times over baseline in 
the first hour after cocaine administration, and it could still be high for as long as a few days later 
(Mittleman et al., 1999). 
 
A survey carried out in the US estimated that frequent cocaine users had a seven-fold higher risk 
of non-fatal myocardial infarction than non-users. Overall, it was estimated that a quarter of non-
fatal myocardial infarctions in persons aged 18–45 were attributable to frequent cocaine use 
(Qureshi et al., 2001). 
 
The most common cardiovascular disorders related to cocaine are ischaemia and acute coronary 
syndrome, which can occur with all the administration routes of cocaine. Other cardiac problems 
include arrhythmias, myocarditis and cardiomyopathy (Egred and Davis, 2005; Wood, 2010).  
 
Although chest pain is the most common cardiovascular symptom in cocaine users, only a small 
proportion (6 %) is attributable to myocardial ischemia or myocardial infraction (Egred and Davis, 
2005; Pozner et al., 2005). Cocaine users who present with acute chest pain may actually have 
acute myocarditis (inflammation of the heart muscle), rather than acute myocardial infarction. 
Myocarditis induced by cocaine may be either toxic myocarditis, which is dose-dependent, or 
hypersensitivity myocarditis, which is not related to dose. In the event that the chest pain is non-
ischaemic, many cases may result from an extracardiac cause including barotraumas related to 
cocaine smoking or inhalation, such as pneumothorax (a collection of air in the space around the 
lungs) and pneumoperitoneum (a collection of air in the abdominal cavity) (Pozner et al., 2005).  
 
Cardiac arrhythmia (irregular heartbeat) may be life-threatening and requires prompt treatment. A 
wide range of arrhythmias has been reported to be associated with cocaine use; these conditions 
are usually transient and resolve when cocaine is metabolised. 
 
Endocarditis (inflammation of the internal lining of the heart chambers and heart valves) has been 
associated with intravenous injection of many illicit drugs, including cocaine (Chambers et al., 
1987; Qureshi et al., 2001). However, cocaine use seems to be a greater independent risk factor 
for developing endocarditis than does the use of other drugs. Furthermore, intravenous injection of 
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cocaine may present an additional, independent risk for the development of endocarditis. It is 
presumed that the increases in heart rate and blood pressure that result from cocaine use may 
lead to valvular and vascular injury that predisposes to bacterial invasion, and the 
immunosuppressive effects of cocaine may also increase the risk of infection (Egred and Davis, 
2005; Pozner et al., 2005). 
 
Aortic dissection is a potentially life-threatening condition in which there is bleeding into and along 
the wall of the aorta, a major artery in the chest. Cocaine use can cause both acute and chronic 
dissection of the aorta (Brownlow and Pappachan, 2002) and lead to acute aortic dissection, 
probably resulting from the severe transient increase in systemic arterial pressure caused by the 
drug. 
3.2 Cerebrovascular disorders and neurological impairments 
 
Acute and chronic cocaine use may cause either haemorrhagic or ischaemic stroke 
(cerebrovascular accident) — an acute neurological condition in which the blood supply to a part of 
the brain is interrupted. 
 
Cocaine-related seizures (temporary abnormal electrophysiological phenomena of the brain, 
resulting in abnormal synchronisation of electrical neuronal activity) occur most often after chronic 
use, but may also occur after the initial use of cocaine via any route of administration. Most 
cocaine-related seizures occur within minutes of use, and almost always within 90 minutes (when 
there is peak concentration of cocaine in the blood) (Boghdadi and Henning, 1997). Cocaine-
induced seizures are usually single, generalised (where most of the brain is affected), tonic-clonic 
(‘grand mal’) seizures. However, status epilepticus (a convulsive seizure that continues for a 
prolonged period — longer than five minutes — or when convulsive seizures occur one after the 
other with no recovery between) can also occur after cocaine use. Cocaine-induced seizures can 
occur in patients with or without a history of seizure disorder. The prevalence of cocaine-induced 
seizures is twice as high in subjects with a history of non-cocaine-related seizures than in those 
without a history of seizure disorder. Seizures caused by cocaine may be lethal, primarily because 
of associated cocaine-induced hyperthermia, systemic acidosis, cardiac dysrhythmias and cardiac 
arrest. 
3.3 Cocaine and alcohol  
 
The combination of alcohol and cocaine is popular among some drug users, perhaps because of 
the more intense feelings of ‘high’ achieved, which is perceived as better than that from either 
substance alone. In addition, cocaine makes the effect of alcohol inebriation less intense and 
alcohol tempers the discomfort felt when ‘coming down’ from a cocaine high (Pennings et al., 
2002). Some users take cocaine simultaneously with alcohol to enable them to drink for longer 
(EMCDDA, 2011; Gossop et al., 2006).  
 
Prospective studies show that simultaneous consumption of cocaine and alcohol increases the 
heart rate with a greater than additive effect, as well as increasing systolic blood pressure and 
impairment of cognitive and motor functions (Pennings et al., 2002). Furthermore, compared with 
cocaine use alone, concomitant consumption of cocaine and alcohol increases blood levels of 
cocaine by up to 30 % (Farré et al., 1993; Perez-Reyes and Jeffcoat, 1992). However, 
retrospective studies suggest that combined use does not cause more cardiovascular problems 
than expected from the additive effects of each drug (Pennings et al., 2002).  
 
Importantly, the concomitant use of alcohol and cocaine results in the formation of a new 
substance, cocaethylene (Herbst et al., 2011), a pharmacologically active metabolite synthesised 
in the liver (Brzezinski et al., 1994). There is some controversy over whether cocaethylene or 
alcohol-induced increases in cocaine levels are responsible for an increased heart rate, and 
presumed increased cardiotoxicity. Because of its pharmacological properties, such as slower 
clearance, longer elimination half-life and larger volume of distribution, cocaethylene persists 
longer in body fluids and tissues than the metabolites of cocaine taken without alcohol, and high 
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blood levels of cocaethylene are therefore found during users’ post-mortems. This led researchers 
to conclude that it has higher toxic potency than cocaine (Lepere and Charbit, 2002). Cocaethylene 
produces cocaine-like cardiovascular and subjective effects, but discrimination of these from the 
direct synergistic effects of the cocaine–alcohol combination is difficult. Cocaethylene, however, 
appears to be less potent than an equivalent dose of cocaine (Hart et al., 2000; McCance et al., 
1995; McCance-Katz et al., 1993). 
3.4 Cocaine and heroin 
 
An increasing number of drug users in Europe report dual dependence on cocaine and heroin 
(EMCDDA, 2007). Opioid users who also use cocaine may take the drugs simultaneously or 
separately. Among drug users, the simultaneous injection of heroin and cocaine is often referred to 
as ‘speedballing’. In this case, the cocaine is either injected in a mixture with heroin or is injected 
immediately before or after the heroin. Many heroin users report co-use of cocaine in a sequential 
manner, either to enhance euphoria or to reduce the withdrawal symptoms commonly experienced 
during a typical day or when attempting self-detoxification from opioid drugs. Compared to cocaine 
users who do not use heroin, those who combine cocaine and heroin are more likely to inject, and 
are likely to inject with a greater frequency because of cocaine’s short half-life. Consequently, there 
is an increase in the health risks related to injecting, such as contracting HCV, HIV and other 
blood-borne infectious diseases (Leri et al., 2003). 
 
The cardiovascular effects of cocaine are amplified when it is co-administered with opioids 
(EMCDDA, 2007). Studies on laboratory animals indicate that morphine (the substance to which 
heroin is converted/metabolised in the body) may enhance the toxic potential of cocaine and that 
cocaine, like morphine, induces respiratory depression, possibly contributing to the ultimate 
mechanism of death in narcotic overdose cases (Polettini et al., 2005; Tseng et al., 1991). 
 
In this section we have discussed the general health consequences of cocaine use. Some of 
these, such as cardiovascular and psychiatric acute episodes, are likely to lead to a visit to an 
emergency department. The next section concentrates on drug-related health emergencies, with a 
focus on cocaine, and presents the data collection systems and their results from 20 European 
countries. It is important to note that the episodes reported from emergency settings are likely to 
represent the visible and most severe consequences of cocaine use: there may also be 
unrecognised and unreported cases. 
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4. Drug-related health emergencies, with a focus on cocaine: data 
collection systems and results  
As detailed in Section 2, EMCDDA key epidemiological indicator drug-related death experts in 30 
countries were asked about their country’s system of collecting data on drug- and cocaine-related 
emergencies from hospital emergency departments and whether or not there were any research 
studies on this issue. Information on these was received from eight countries. 
 
The 30 countries’ annual National reports from the REITOX national focal points to the EMCDDA 
for the period 2007–11 (published in 2008–12) were scrutinised for relevant data on drug-related 
emergencies, with particular attention given to cocaine-related mentions, data sources, case 
definition, coverage, case characteristics and long-term trends. These data were found in reports 
from 20 countries, although in some cases they were very sparse and were not always collected 
across the whole country. For these 20 countries, data from the 2011 National reports (published in 
2012) were scrutinised for relevant data on hospital visits due to driving while using the drug. 
Finally, where available, statistics reported by the national focal points to the EMCDDA on cocaine-
related cases in hospital emergency departments or other settings from 1999 to 2011 were used to 
identify long-term trends.  
 
The above strategies resulted in information for a total of 20 countries (19 on drug-related 
emergencies (4) and one on road traffic accidents only (5) (see Table 1).  
                                               
(4) Belgium, Bulgaria, the Czech Republic, Denmark, Germany, Estonia, Ireland, Spain, France, Italy, Cyprus, Latvia, 
Lithuania, Hungary, Malta, Netherlands, Romania, Slovenia, the United Kingdom. In addition, the DRD experts in Finland 
and Austria responded to the questionnaire to report that there are no data available on drug-related emergency hospital 
visits. 
(5) Norway. 
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Table 1: Brief case definition, setting and sources of drug-related emergency episodes, by 
country, as reported in the National reports. 
 
Country Case definition 
 
Setting and source 
 
 
Belgium 
 
 
Requests for information from the general public 
and health professionals 
National Poison Information Centre † 
Inpatient admissions with substance-related 
disorder (Minimal Psychiatric Data — MPD) 
 
Psychiatric hospitals 
Belgium Federal Public Service 
 
 
Bulgaria  
 
 
Persons requiring emergency medical aid due to 
drug-related problem 
Clinic of Toxicology of the ‘ Nikolaj 
Ivanovich Pirogov’ multiprofile hospital for 
active treatment and emergency medicine 
(MHATEM) 
Non-fatal drug-related emergencies due to acute 
poisoning 
Ministry of Health data. Hospital Centres for 
Emergency Medical Aid (CEMA) ∆ 
 
 
 
Czech 
Republic* 
 
Cases of non-fatal intoxication with drugs Sentinel-type system operated by the public 
health service † 
Cases hospitalised for more than 24 hours 
following intoxication with addictive substances 
(since 2011) 
National Register of Hospitalisations 
(NRHOSP) managed by the Institute of 
Health Information and Statistics 
 
 
 
Denmark 
Cases admitted as a result of poisoning with illicit 
drugs  
Hospital emergency departments†. LPR – 
Landspatientregistret, or National Patient 
Register 
 
Admissions with a drug-related primary or 
secondary diagnosis (co-morbidity) 
 
Psychiatric hospitals † 
 
 
Germany 
Reported non-fatal overdose by drug users in 
cross-sectional interviews  
MoSyD study of the Frankfurt scene 
Reported overdoses and life-threatening 
emergencies by drug users on the drug scene 
and from a substitution practice facility 
 
Study in 10 cities by the Centre for 
Interdisciplinary Addiction Research of the 
University of Hamburg (ZIS) ∆ 
Estonia Cases receiving first aid for overdoses Emergency ambulance service (Tallinn) # 
Ireland Admissions related to non-fatal overdose 
(discharges) 
 
Hospital† HIPE (Hospital In-Patient 
Enquiry), a computer-based health 
information system on coded discharge 
summaries 
 
Spain 
 
Episodes directly related to non-therapeutic use 
of psychoactive drugs  
 
Hospital emergency departments ∆ 
France Data from survey among drug users only ENa-CAARUD (Centre d’accueil et 
d’accompagnement à la réduction des 
risques pour usagers de drogues) 
 
 
 
Italy*µ 
Hospital admissions with primary or secondary 
diagnoses related to psychoactive drug use 
Italian Ministry of Health 
Analysis of the mortality of the patients admitted 
to hospital for drug-related causes  
 
Italian Ministry of Health 
Cyprus Non-fatal drug-related cases Hospital emergency departments  ∆ 
Latvia 
 
Drug overdose case discharges Department of toxicology (one hospital — 
Riga Eastern Clinical University Hospital 
Toxicology Centre) # 
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¢ Data are derived from a representative selection of hospitals and extrapolated to yield national estimates. 
Coverage: # local; † national; ∆ some regions only. 
* Countries that reported on road traffic accidents in 2011 National reports (published in 2012). 
µ
 Deaths and acute intoxications related to new psychoactive substances can also be reported from the national early-
warning system — Department of Antidrug Policies, Presidency of the Council of Ministers.  
  
Lithuania Hospital inpatient drug-related cases  Medical institutions †  State Patients Funds 
 
Hungary* Cases treated for intoxication by illicit drugs or 
organic solvents  
Department of Toxicology (one hospital) # 
(Clinical Toxicology Department of Péterfy 
Sándor Street Hospital in the Municipality of 
Budapest) 
 
Malta Number of non-fatal overdoses  Police drug squad records † 
 
 
Netherlands 
 
Cases with accident, violent incident or self-
mutilation related to drug use, from Letsel 
Informatie Systeem (LIS) 
Hospital emergency departments ¢ † 
Drug-related incidents, from Monitor Drugs 
Incidenten (MDI) (sentinel system not attempting 
to estimate the actual number of cases) 
Police, ambulance transportation services, 
hospitals and two organisations on first aid 
at dance parties (in eight regions) ∆ 
Drug-related requests for emergency assistance  Central Post for Ambulance Transports # 
Information requests from physicians, health 
authorities and others on acute intoxications 
National Poison Information Centre 
(NVIC) † 
Clinical admissions in general hospitals due to 
cocaine misuse or dependence (primary or 
secondary diagnosis), from the National Drug 
Monitor 
Trimbos-instituut (the Netherlands Institute 
of Mental Health and Addiction). Dutch 
Hospital Registration, held by the Dutch 
Hospital Data Foundation. Hospitals † 
 
Romania Non-fatal emergencies due to intoxication by illicit 
drugs 
Emergency departments at hospitals † 
Slovenia Inpatient admissions  Emergency Medical Department, University 
Medical Centre in Ljubljana # 
Hospitalisations due to mental and behavioural 
disorders related to the use of psychoactive 
substances 
 
Hospitals † 
 
 
 
United 
Kingdom* 
Inpatient discharges recording poisoning by 
drugs (including secondary diagnosis) 
Hospitals † 
Psychiatric inpatient discharges with a diagnosis 
of drug misuse  
Hospitals † 
Hospital inpatient admissions from England, 
Scotland, Northern Ireland and Wales. The data 
for England uses primary diagnosis only but 
provides the longest trend data with records 
available from the end of the 1990s 
Hospital activity (Hospital Episode Statistics 
— HES). Patient Episode Database Wales. 
ISD Scotland Inpatient and Day Case 
Activity. Northern Ireland Hospital Statistics 
Hospitals † 
 
Norway* Data on road traffic accidents only Oslo University Hospital (Ullevål) and 
Norwegian Institute of Public Health 
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• Fifteen of the most recent National reports (delivered in 2011 and published in 2012) 
reported on cocaine-related emergency cases. In Spain, data from emergency departments 
revealed 2 386 cases directly related to cocaine in 2011 (EMCDDA, 2013c).  
 
• In the United Kingdom, 2 247 inpatient discharges recorded cocaine poisoning and 4 209 
inpatient discharges recorded mental and behavioural cocaine-related disorders in 
2010/2011.  
 
• Italy reported 1 898 hospital admissions related to cocaine in 2009.  
 
• Hospital emergency departments in the Netherlands reported an estimated 1 176 cases 
annually of accidents, violent incidents or self-mutilation related to cocaine use in 2011. In 
the same year there were also: 896 clinical admissions; 219 calls for information about 
acute intoxications involving cocaine to the National Poison Information Centre from 
physicians, health authorities and others; 188 cocaine-related incidents reported by the 
police, ambulance transportation services, hospitals and two first aid organisations at dance 
parties; and 179 cocaine-related requests for emergency assistance to the Central Post for 
Ambulance Transports. 
 
• Danish emergency departments recorded 150 cases of cocaine poisoning in 2011.  
 
• In Ireland there were 94 cases of discharge from hospitals after a non-fatal cocaine 
overdose in 2010.  
 
• There were 147 cocaine-related emergency cases reported from Romania in 2011. 
 
• In Hungary, 22 cases were treated for cocaine-related intoxication at the department of 
toxicology of one hospital in 2011. 
 
• Five other countries also reported cocaine-related emergency cases in 2011: Belgium (16), 
Bulgaria (30), Lithuania (14), Slovenia (10), the Czech Republic (1). 
 
• Four countries reported cases related to drug use but did not specify numbers related to 
cocaine: Cyprus, Malta, Latvia and Estonia. 
 
• Norway reported only on drug-related road traffic accidents in 2009. 
 
• Germany and France did not report any information on cocaine-related emergency cases 
from hospitals, although studies among problem drug users provided some insight into the 
frequency and number of cocaine-related overdose or incidents. 
 
According to the most recent available information for each country (which in some cases is 
several years old), the highest number of cases were reported from the United Kingdom, Spain, 
Italy, Denmark and the Netherlands (Table 2). 
 
Table 2: Age, gender and last year trend of the reported cases of illicit drug- and cocaine-
related episodes in the latest data available in the National reports. 
 
Country Age: age bands or mean age 
(cases related to all drugs or to 
cocaine) 
Gender (proportion 
of males) 
Last year trend in number 
of cocaine-related cases 
Belgium No data No data Stable 
16 in 2011 
(18 in 2010) 
Bulgaria 80 % aged 19–35 (all drugs, 2010) 74 % (all drugs, 
2010) 
Increase 
30 in 2011 
(12 in 2010) 
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Czech 
Republic 
No data No data Stable  
1 in 2011 
(0 in 2010) 
Denmark 30 % older than 30 years (cocaine, 
2010) 
55 % older than 30 years (all 
drugs, 2010) 
Most common age band for 
stimulants, including cocaine: 20–
24 years 
66 % (all drugs, 
2011) 
Stable 
150 in 2011 
(155 in 2010) 
Germany No data No data No data 
Estonia No data No data No specific data on cocaine 
Ireland 66 % aged 25 or older (all drugs, 
2010) 
 Stable 
94 in 2010 
(92 in 2009) 
Spain Mean age 33.3 years (cocaine, 
2010) 
Younger than heroin users (36.2) 
and users of other opioids (37.8). 
Older than users of volatile 
substances (24.6), hallucinogens 
(27) and ecstasy (28.6) 
Mean age: 27.8 in 2008 (all drugs). 
Increased to 33 in 2010 
80 % (cocaine, 
2009). 
Decrease to 74.5 % 
(cocaine, 2010). 
Same decrease in 
the % of males 
observed for other 
drugs as well 
Decrease 
2 386 in 2011 
(2 779 in 2010) 
France No data No data No data 
Cyprus No data No data Stable  
4 in 2011 
(4 in 2010) 
Italy Mean age 40 years for males and 
46 for females (all drugs, 2009) 
58 % (all drugs, 
2009) 
No trend data. 2 408 in 2008. 
1 898 cocaine-related 
hospital admissions in 2009. 
Data not updated 
Latvia Mean age 25 years (all drugs, 
2011) 
80 % (all drugs, 
2011) 
No specific data on cocaine 
Lithuania Mean age 28.6 (all drugs, 2011) 77 % (all drugs, 
2011) 
Increase 
19 in 2011 
(14 in 2010) 
Hungary 18 % aged 20–24; 19 % aged 25–
29; 18 % aged 30–34 (all drugs, 
2010) 
85 % (all drugs, 
2010) 
Decrease 
22 in 2011 
(67 in 2010) 
Malta No data No data No specific data on cocaine 
The NL (MDI) 43 % older than 25 (dance parties 
component of the MDI, 2011) 
39 % aged 18–24 (all MDI, 2010) 
Median age 31 (all MDI, incidents 
related to cocaine-only use, 2010) 
Two-thirds males (all 
MDI, 2010) 
79 % (all MDI; 
incidents related to 
cocaine-only use, 
2010) 
Changes in coverage. 
Cannot analyse trend. 
In 2011, total of 3 652 
emergencies of which: 
ambulance transportation 
services, 2 022; hospital 
emergency departments, 
257; forensic doctors, 327; 
emergency posts at dance 
parties, 1 046. 
The NL 
(Ambulance 
Amsterdam) 
No data No data Increase 
179 in 2011.  
(130 in 2010) 
The NL (LIS) 47 % aged 20–29 years (all drugs, 
2006–10 estimate) 
74 % (all drugs, 
2006–10 estimate) 
Changes in the % of those 
with known substances. 
Cannot analyse trends 
The NL 
(Poison 
Centres) 
No data No data Decrease  
219 in 2011 
(243 in 2010) 
The NL 
(National 
No data No data Increase 
896 in 2011 
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Monitor) (870 in 2010) 
Romania 45 % aged 24 or older and 25 % 
aged 25–34. Mean age 25 (all 
drugs, 2011) 
73 % (all drugs, 
2011) 
147 cocaine-related 
emergencies in 2011 
Slovenia 
(admission) 
Mean age 33 (cocaine, 2011) 
Mean age 29 (all drugs, 2011) 
67 % (all drugs, 
2011) 
All 10 cases males 
10 cases in 2011 
Slovenia 
(psychiatry) 
No data No data Stable 
4 in 2011 
(6 in 2008) 
UK (inpatient 
discharges 
poisoning) 
No data No data Increase 
2 247 in 2010–11 
(1986 in 2009–10) 
Still at a lower level than in 
2007–08 and in 2008–09 
UK (drug 
misuse 
diagnostic) 
No data No data Increase 
4 209 in 2010–11 
(3 502 in 2009–10) 
UK — England 
(inpatient 
admission, 
primary 
diagnosis) 
No data No data Decrease 
662 in 2011–12 
(727 in 2010–11) 
Norway No data No data No data 
 
 
4.1 Data collection sources and results, country-by-country 
 
The information that was collected from each country is presented in Annex 1, the case 
characteristics are summarised, and long-term trends in cocaine-related emergency cases are 
extracted from the data. 
  
 
4.2 Cocaine-related emergency case characteristics  
 
This section summarises the available information on the age and gender, clinical characteristics 
and outcomes of cocaine-related emergency cases. 
 
The information on the age and gender of cases of drug- and cocaine-related emergencies 
reported in the National reports varied across countries: the level of detail provided and the age 
bands used were not standard (see Table 2). In some cases, the age breakdown for all drug-
related episodes was presented and the drugs responsible were not specified. In such instances, 
the age and gender of all drug-related cases can be used as a proxy, although some reports, such 
as those from Spain and Denmark, suggest that cocaine-related episodes might be seen in users 
younger than users of other drugs, particularly heroin users. 
 
Where specific information is available on drug-related episodes, only Spain and one indicator of 
the Netherlands report age and gender specifically on cocaine-related incidents. The information 
available for the other countries relate to all drugs, with no breakdown by substance. Males 
typically account for three-quarters or more of the reported cases. However, the proportion of 
males is relatively smaller in Denmark, Italy and Slovenia; and in Spain and Hungary the proportion 
of males has decreased compared to previous years. Changes in the gender ratio are not reported 
from other countries, making comparison between countries impossible (see Table 2).  
 
Overall, for both drug- and cocaine-related episodes, most cases were male and in their twenties 
or thirties. Data from emergency departments in Spain show an increasing mean age of the 
patients. Italy and Hungary report that females are slightly older than males. For example: 
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• The mean age in Italy of the reported drug-related cases was 40 years for males and 46 
years for females in 2009. 
 
• 76.5 % of the reported drug-related emergency department cases in Spain in 2010 were 
males, and the mean age of all patients was 32.6 years (33.0 for males and 31.6 for 
females). The average age of the emergency cases where the physician stated a direct 
relationship with cocaine was 33 years. 
 
• 74.5 % of the reported cocaine-related emergency department cases in Spain in 2010 were 
males, a decrease compared to 80 % in 2009. 
 
• In the Netherlands from 2006–10, estimates from Letsel Informatie Systeem (LIS) on the 
number of people treated annually at a hospital emergency department following an 
episode related to drug use reveal that 47 % of a total of 4 270 were aged 20–29 and 74 % 
were male. Over this period, poisoning was the most frequent cause of the emergency 
(74 %).  
 
Information on the clinical characteristics of the cases is often limited and is not standardised, 
although most drug-related and cocaine-related emergencies reported in the National reports seem 
to be coded as poisoning or overdose. For example, in the Netherlands from 2006–10, around 
4 270 people were treated annually at a hospital emergency department following a drug-related 
accident, violent incident or self-mutilation. Of these cases, poisoning was the most frequent cause 
of the emergency (75 %). 
 
Only some countries report data on the number of psychiatric episodes among drug users seen at 
hospitals, and hospitalisations in psychiatric wards due to drug-related problems: Belgium, 
Denmark, Slovenia and the United Kingdom.  
 
Where information is available, polydrug use seems to be frequent in drug-related emergency 
cases. In Belgium around half of the cocaine-related admissions were due to cocaine alone and 
the other half was due to cocaine taken with other drugs. Data from the poison centres also show 
that some polydrug-related cases involve cocaine. In Denmark polydrug was the largest group of 
drug-related psychiatric admissions, and in Romania it is the second most frequent cause of acute 
intoxication with drugs after ‘ethno-botanicals’. In Germany polydrug use was the main reason 
reported by the drug users as having caused their overdose, but no specific information was 
reported on cocaine.  
 
The severity of cocaine-related cases was reported only from the Netherlands, where a monitor of 
drug-related emergencies (MDI) reported that intoxications with cocaine in 2010 were most often 
categorised as ‘light’ (43 %) or ‘mild’ (44 %). Only 13 % of the cocaine intoxications were 
categorised as ‘severe’, in contrast to higher proportions for opioids (33 %) and GHB (31 %). Just 
over one-third (36 %) of the 188 ‘severe’ cocaine-related cases resulted in hospitalisation, 
compared with 58 % of the cases related to opiates and 46 % of those related to GHB. The 
severity of the episode is, however, approximated in some of the national reports by the proportion 
of cases that are hospitalised following the emergency episode. This is not reported systematically, 
though, and may depend on the referral systems and structure of the care system rather than only 
on the severity of the case. 
 
Reporting the outcome of a cocaine-related emergency episode was very rare, particularly for 
death. Data from Italy, however, show that around one in 20 (6 %) of the hospital admissions 
related to cocaine ended in death compared with about a third (32 %) of admissions related to 
opiates. Where available, data show that most cases related to cocaine are discharged after the 
emergency episode. For example, the most frequent outcome of emergency cases in 2009 in Italy 
was discharge to home, for around eight in ten cases, followed by self-discharge for around one in 
ten. The other cases were transferred to another facility and less than 1 % of the cases with 
emergency episodes died. In Spain in 2009 the outcomes of the 3 413 cases of cocaine-related 
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emergencies were mainly discharge (81.2 %), self-discharge (8.7 %), hospital admission (7.5 %) 
and transfer to another hospital (2.5 %).  
 
 
4.3 Trends in cocaine-related episodes  
 
The data from many countries do not allow for long-term trend analysis, although this was possible 
for four countries among those that report the highest number of emergency cases in Europe — 
Denmark, England (because long-term data for the United Kingdom as a whole were not 
available), Spain and the Netherlands. These data are shown in Figures 1–4, in Annex 1.  
 
There was an increase in the number of cocaine-related emergency episodes from the late 1990s 
until 2007–2008. In Spain and the United Kingdom, these increases appear to have peaked 
around 2007–08 and have subsequently dropped. These two countries have a large proportion of 
the overall European reported number of cocaine-related emergency cases and thus impact 
heavily on the overall European total. The overall trend is consistent with changing prevalence of 
use among the young population; with rates of cocaine-related deaths; and with the number of 
people entering treatment with cocaine as the primary drug (EMCDDA, 2013b; 2013c). 
 
The picture varies between countries, however, and is complex (see Figures 1–4 in Annex 1 and 
Table 2 for most recent trends in all countries). The trends also vary within countries, such as the 
Netherlands, where, between 2010 and 2011, some indicators showed an increase and others a 
decrease in the number of cocaine-related emergencies. 
 
According to the most recent data, the decreasing trend is not reported by all data collection 
systems in all countries. Six systems report an increase, four a decrease and six a stable level 
(Table 2). For many other systems the trends are not available, or the coverage of the surveillance 
system has changed, which impedes comparisons.  
 
In many countries the numbers reported are small and trend analysis should be conducted 
cautiously (Table 2).  
 
This overview of the most recent trends for all countries, using data from 2011, is completed in 
Table 3, which summarises the trends observed in 2009 or 2010 (depending on the available data) 
compared with the previous two years. Trends in the six countries (6) where the data collection 
systems reported more than 50 cases of cocaine-related emergencies annually were examined in 
details (other countries were excluded, as trend comparison is difficult with smaller numbers). 
Table 3 presents cocaine-related episodes as a proportion of all drug-related episodes and 
documents changes over time, both for all drugs and for cocaine.  
 
 
                                               
(6) Denmark, Ireland, Spain, Hungary, the Netherlands, the United Kingdom. 
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Table 3: Number of cases and trends in illicit drug- and cocaine-related episodes from 
collection systems that reported more than fifty cocaine-related cases in the 2010 
(published in 2011) National reports to the EMCDDA 
(modified from Mena et al., 2013&) 
 
 
&
 Original source : Mena, G. et al. (2013), European Addiction Research, 19, pp. 74–81. Permission granted by S. Karger 
AG, Basel, Medical and Scientific Publishers. 
* Trends were analysed by comparing the latest number of reported cases with the average number of cases in the two 
previous years. In the Netherlands (A), illicit drug trends and cocaine trends (A and B) were calculated by a comparison 
only with the number of cases in the previous year. 
** Average number over the 2005–09 period, national estimates based on sample data. 
*** Secondary diagnosis only of abuse or dependence: there were 114 cases with a primary diagnosis. 
# Trends in the proportion of cocaine-related cases over all illicit drug-related cases were analysed using the Chi-square 
test (p<0.05). 
 
Country 
(year) 
 
Case definition, setting and source 
 
 Illicit drug-
related cases 
N / Trend* 
Cocaine-related 
cases 
N / Trend* 
% of cocaine 
over illicit 
drug cases / 
Trend# 
 
Denmark  
(2010) 
 
Cases admitted as a result of poisoning with 
illicit drugs at hospital emergency 
departments 
 
1 868 /↑16.7 % 
 
155 /↑16.8 % 
 
8.3 % /↔ 
Hungary 
(2010) 
Cases treated for intoxication of illicit drugs 
or organic solvents at the department of 
toxicology of one hospital 
 
1 962 /↑10.8 % 67 /↑12.7% 3.4 % /↔ 
Ireland 
(2009) 
Non-fatal overdoses discharge at hospitals 4 172 /↓16.1 % 92 /↓37.0 % 2.2 % /↔ 
 
 
 
 
 
 
 
 
 
Netherlands  
(2010) 
 
A. Drug-related incidents reported by the 
police, ambulance transportation services, 
hospitals and two organisations providing 
first aid at dance parties from Monitor Drugs 
Incidenten (MDI)  
 
2 852 /↑11.5 % 
 
188 /↓47.9 % 
 
6.6 % /↓ 
 
 
B. Drug-related requests for emergency 
assistance at the Central Post for 
Ambulance Transports, Amsterdam  
 
1 306 /↑18.6 % 
 
130 /↓10.8 % 
 
10.0 % /↓ 
 
C. Cases with accident, violent incident or 
self-mutilation related to drug use at 
hospital emergency departments from 
Letsel Informatie Systeem (LIS) 
 
4 270**  1 211** 28.4 % 
 
D. Information requests from physicians, 
health authorities and others on acute 
intoxications to the National Poison 
Information Centre 
 
1 243 /↑4.7 % 243 /↓1.4 % 19.5 % /↔ 
E. Clinical admissions in general hospitals 
due to cocaine abuse or dependence 
(primary or secondary diagnosis) 
 
 
2 800*** 
/↑24.1 % 
756*** /↑27 %% 31.5 % /↓ 
Spain 
(2009) 
 
Illicit drug-related cases with a direct 
relationship to cocaine in emergency 
departments at hospitals 
5 567 /↓28.0 % 2 845 /↓36.2 % 51.1 % /↓ 
 
United Kingdom 
(2010) 
 
 
A. Inpatient discharges recording poisoning 
by drugs at hospitals  
 
 30 618 /↑1.5 % 1 986 /↓25.1 % 6.5 % /↓ 
B. Inpatient discharges with mental and 
behavioural drug-related disorders at 
hospitals  
 
22 271 /↑5.0 % 3 502 /↓21.2 %  15.7 % /↓ 
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The proportion all drug-related episodes that features cocaine varied in the six countries and 11 
systems analysed, reflecting the differences in the types of cases captured, and in the prevalence 
of use of cocaine and other drugs. For example, cocaine represented a tenth or less of all drug-
related cases in six systems. It represented more than a quarter of the cases in two systems in the 
Netherlands and more than half of the cases in Spain.  
 
The changes over time seen in 2010 compared to the previous two years were confirmed in Spain 
in 2011. The numbers stabilised in Denmark and Ireland, and the trend reversed in Hungary where 
the numbers decreased in 2011, as well as in the United-Kingdom where the numbers increased in 
2011. In the Netherlands the picture was mixed and incomplete as two indicators did not allow 
trend comparison. The previous increasing trend in hospitalisation was confirmed in 2011; 
however, the trend in calls to poison centres reversed, with an increase in 2011. The trend in the 
numbers reported by the ambulance services in Amsterdam also reversed, with an increase in 
2011. 
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5. Discussion 
 
5.1 Data sources on hospital emergencies in Europe  
 
In Europe there is no overall systematic data collection on hospital emergencies, which makes it 
difficult to obtain a general picture.  
 
The reported information on drug- and cocaine-related hospital emergencies in Europe is limited to 
a few countries and, until this publication, has not been systematically collated. One of the main 
findings of this report is that the majority of the European countries report some information on 
drug-related emergencies, based on a wide range of different settings and sources. Information on 
illicit drug-related emergencies was retrieved for 20 of the 30 countries that report data annually to 
the EMCDDA. Most of these (excluding Denmark, Germany and Estonia) include some data on 
cocaine-related health problems. A total of 33 data sources were cited, as nine countries (Belgium, 
Bulgaria, the Czech Republic, Denmark, Germany, Italy, the Netherlands, Slovenia and the United 
Kingdom) have more than one data collection system. 
 
Another important finding of this study is the variety and heterogeneity of the sources used 
(primarily hospital emergency services, but also including poison centres, first aid services for drug 
users, police drug squad reports), and therefore of the types of cases reported (see Tables 1 and 2 
and Annex 1 for further details by country). Many countries report data from more than one source 
(Table 1).  
 
In most countries, data are collected from hospitals:  
 
from emergency departments in seven countries (Bulgaria, Denmark, Spain, Cyprus, the 
Netherlands, Romania and Slovenia);  
 
from toxicology departments or clinics in three countries (Bulgaria, Latvia and Hungary);  
 
from discharge records following hospitalisation because of poisoning by illicit drugs in four 
countries (the Czech Republic, Ireland, Lithuania and the United Kingdom); and 
 
from psychiatric hospitals or diagnostics in four countries (Belgium, Denmark, Slovenia, the 
United Kingdom). 
 
Data collection systems on emergencies that are not based on hospital statistics are reported by 
five countries:  
 
cases in which services provided first aid for drug users were reported from Estonia and the 
Netherlands; 
 
calls for information about cocaine to the National Poison Information Centre from 
physicians, health authorities and others on acute intoxications were reported from Belgium 
and the Netherlands; 
 
cases from the police drug squad records were reported from Malta;  
 
data on drug-related road traffic accidents were reported from Norway, but there were no 
data from emergency settings.  
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Data not directly related to emergencies were reported from France and Germany:  
 
findings from surveys among drug users accessing low-threshold services (CAARUD) from 
France; 
 
the results of the MoSyD study on drug trends from Germany.  
 
The situation in Europe contrasts with that in the United States of America, where a structured 
system of data collection (DAWN) has valuable uses. In the US national estimates of drug-related 
visits to hospital emergency departments are obtained from the Drug Abuse Warning Network 
(DAWN) (7), a public health surveillance system managed by the Substance Abuse and Mental 
Health Services Administration (SAMHSA), US Department of Health and Human Services (HHS). 
DAWN data are based on a national sample of general, non-federal hospitals operating 24-hour 
emergency departments. Information is collected for all types of drugs, including illicit drugs, 
inhalants, alcohol, prescription and over-the-counter (OTC) medication, and dietary supplements. 
Structured information is reported weekly. 
 
DAWN data are widely used to help monitor problems related to drug use in general, including 
cocaine (see Annex 2 for further detail). Data on individuals who experience drug-related medical 
emergencies severe enough to require treatment in an emergency department provide important 
information on the types of drugs involved in problem substance use and the characteristics of 
those who suffer the negative consequences of use. 
 
 
5.2 Cocaine related hospital emergencies in Europe 
 
We found, unsurprisingly, that the highest numbers of cocaine-related emergency episodes were 
reported from countries with a known high prevalence of cocaine use among young adults: 
Denmark, Ireland, Spain, the Netherlands and the United Kingdom. These countries have a 
prevalence of cocaine use in the population aged 15–34 that is above the European average 
(EMCDDA, 2013a). 
 
Where information was available, most cases were males and young adults, consistent with data 
from general population surveys (EMCDDA, 2013b, 2013d). Some of the cocaine-related 
emergency cases occur against a background of polydrug use. This is mirrored by the findings of 
some studies of cocaine-related cases in emergency settings as well as by cocaine-related deaths, 
which often involve other drugs (EMCDDA, 2013c; Pavarin et al., 2011; Santos et al., 2012; 
Corkery, 2012).  
 
There was a two- to three-fold increase in cocaine-related emergency episodes in several 
countries from the late 1990s until 2007–08. This peak in Europe is consistent with the data from 
the US DAWN system, where the number of cocaine-related visits to emergency departments 
peaked in 2007. There was a rebound in numbers in the USA in 2010, but the number of visits is 
still below the number recorded in 2007. Similar to Europe, most cocaine-related cases are young 
and males (see Annex 2 for further details on the DAWN design and recent results).  
 
The most recent European data show a more complex picture and trends vary between countries. 
A decrease in the number of hospital emergency cases during the last reported years was seen in 
the data from Ireland, Spain, the United Kingdom (England in particular) and Hungary (after the 
peak reached in 2010). Based on the most recent data, an increase was reported from Denmark 
(until a stabilisation in 2011), from the United Kingdom as a whole, and from two of the five Dutch 
systems that monitor these emergencies (Ambulance Amsterdam and National Monitor). In 
                                               
(7) dawninfo.samhsa.gov 
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Bulgaria and Lithuania an increase in 2011 compared to 2010 was also reported, but small 
numbers require caution when analysing trends.  
 
Part of the recent decline in cocaine-related hospital admissions and emergencies in some 
countries is mirrored in data on cocaine-related deaths (Bird, 2010; EMCDDA, 2011). The decline 
in cocaine-related hospital admissions may be related to a decline in cocaine purity and/or in 
cocaine use as observed in recent population surveys. It has been hypothesised that in some 
countries there could have been a shift to using alternative stimulants, including ‘legal highs’ which 
seem to have less toxicity than cocaine. Last year use of powder cocaine amongst 16- to 59-year-
olds in England and Wales fell from 3 % in 2008–09 to 2 % in 2010–11 (Smith and Flatley, 2011). 
The mean purity of powder cocaine seized by the police in England and Wales fell from 33 % in 
2007 to 24 % in 2010 and the purity of crack cocaine fell from 52 % to 31 % (United Kingdom 
National Focal Point, 2012). In Spain it was suggested that changes in the availability and purity of 
cocaine, possibly combined with other factors such as increased risk perception or successful 
prevention programmes, could explain a reduction in cocaine-related emergency cases, but there 
is not an apparent switch to other stimulants (Observatorio Español sobre Drogas, 2009). 
 
 
5.3 Limitations of this exploratory report and of the data available through the national 
reports 
 
There are several limitations to the data on drug-related emergencies in Europe that are currently 
available and collated in this report, and analysis must be conducted with caution. Some countries 
do not currently report data on this issue, including some with a known relatively high prevalence of 
cocaine use compared with the EU average, notably France, which, after the United Kingdom, 
Spain, Ireland, Denmark, the Netherlands, Belgium and Cyprus has the eighth highest prevalence 
of last year cocaine use among 15- to 34-year-olds (EMCDDA, 2013a, 2013b).  
 
The quality of the data reported through some of the National reports is sometimes low, although it 
has to be remembered that there has not been an active use of this information or guidelines on 
how to report it. Some national reports provide very limited information of cocaine-related harm, 
with no reference to hospital emergency data (e.g. Germany and France). This kind of information 
should be available, to a certain extent, either at the national or local level, in published papers or 
in reports This study found in particular: that definitions of the cases considered, the settings and 
the coverage were unclear; that the data sources referred to varied over time; that some data 
collection systems have local or regional coverage only; and that the amount of information 
available was insufficient, or not sufficiently standardised to allow comparisons and the 
identification of trends.  
 
Some national focal points including those in Latvia and Hungary, do not yet have access to data 
on drug-related emergencies at the national level and provide data from just one source 
(respectively one hospital in Riga and one in Budapest), while others use a sentinel-type system 
(e.g. the Czech Republic and the Netherlands). The picture provided here is therefore incomplete 
and underestimates the extent of the cocaine-related health problems in Europe.  
 
 
5.4 Challenges of monitoring and analysing acute intoxications through 
retrospective data from clinical or administrative records  
 
The Spanish monitoring system and the Dutch Monitor Drugs Incidenten systems have systematic, 
prospective and long-term data collection systems similar to DAWN in the USA. The sources of 
most of the other countries discussed here are retrospective data from clinical or administrative 
records, however, and this information may sometimes be incomplete or of doubtful validity 
(Domingo-Salvany and Hartnoll, 1999). Some of the reasons for that are detailed below. 
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Underestimation: some hospital systems capture only hospitalised patients  
 
For example, long-term information from the United Kingdom (England), and also from other 
countries, is limited to cases from emergency departments that are admitted to hospitals as 
inpatients. As drug users discharged directly from accident and emergency departments are not 
captured by the database, the data for England are likely to underestimate the prevalence of acute 
toxicity related to cocaine (Wood and Dargan, 2010). As an illustration, a study in a London clinical 
toxicology unit showed that approximately 50 % of those who present to the emergency 
department with drug-related toxicity are admitted to hospital (Wood and Dargan, 2010).  
 
ICD codes: a limited capacity to capture presentations with acute recreational drug toxicity 
in the hospital  
 
Cases may be coded by the symptoms (e.g. chest pain, convulsions, stroke, etc.) rather than as 
being due to cocaine and this is another reason for significant under-representation. There are 
some limitations inherent in the use of ICD-10 for categorising hospital emergency episodes, 
admissions and discharges related to drugs. The ICD-10 codes have specific limitations for cases 
related to new psychoactive substances, for which no codes exist. As an illustration, a study in the 
United Kingdom (Shah et al., 2011) found that hospital admissions due to ‘recreational drugs’ 
without specific ICD10 codes are assigned to a wide variety of primary codes, and/or the use of 
‘recreational drugs’ may not be coded. The authors of this study concluded that further work is 
needed to look at methods of capturing presentations to hospital with acute recreational drug 
toxicity, either by updating the ICD codes or by using a more time-responsive data capture system 
in sentinel hospitals in the UK to monitor trends in acute recreational drug toxicity. 
 
Possibly less recognition of cocaine-related cases compared to cases related to other 
drugs 
 
Under-reporting of cocaine-related emergency cases is also likely to be due to the often unspecific 
or chronic nature of the pathologies typically arising from the long-term use of cocaine, and also to 
the difficulties in establishing causal links between an illness and the use of the drug (de Millas et 
al., 2010; EMCDDA, 2007). For example, in terms of the possible cardiovascular consequences of 
cocaine use, studies have shown that although doctors are aware that cocaine is a risk factor for 
acute coronary syndrome, they are less likely to ask about cocaine use than about classical 
cardiovascular risk factors such as smoking, diabetes and hyper-cholesterolaemia (Wood et al., 
2007). Therefore, for instance, it is likely that doctors do not ask patients presenting with cardiac 
arrhythmias about recent cocaine use. This may partly explain the limited published data in this 
area (Wood and Dargan, 2010). 
 
Different definitions are used when collating the number of cocaine-related emergency episodes, 
and these are often determined by the amount and detail of the information that is recorded and 
accessible. In particular, some countries extract cases retrospectively from hospital databases that 
record only one main diagnosis or ‘cause’ of the incident, as reported from Slovenia; the 
information that cocaine was present and might have played a role can thus be lost. This is the 
case, for example, if a patient has used cannabis, amphetamines, cocaine and alcohol and has an 
accident while under their influence, and in some cocaine-related cardiovascular episodes, as 
described above — the incident may or may not be recorded as a cocaine-related emergency.  
 
Analytical confirmation of the presence and quantification of the drug in emergency 
settings is rare 
 
Many cases of acute intoxication do not undergo a toxicological screening, and a diagnosis is 
therefore based only on a clinician’s examination and interview with the patient. This means that 
most reports of toxicity associated with the drugs are presumptive and that there is no analytical 
confirmation of the specific drug. This is a limitation in particular in the monitoring of harm related 
to new psychoactive drugs. This is either due to the lack of analytical testing of biological samples 
(often this analysis takes too much time to complete to be of use in clinical management); a patient 
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refuses to provide a sample for testing; or there are issues of cost, availability and methodology. 
Analytical confirmation of the presence and quantification of a new drug and or its metabolites in 
the biological fluids should be an essential component of the monitoring systems.  
 
Few papers have been published in most countries 
 
In the questionnaire for the drug-related death experts, we asked if they knew of any research 
studies using data from emergency services in terms of the harms related to drug use, but very few 
were cited. Several countries have published data on this type of monitoring, however, particularly 
Spain, Italy and the United Kingdom. This deserves more attention, as relevant findings should 
have more visibility in European countries in order to inform prevention interventions. 
 
5.5 Drug-related emergencies after road traffic accidents: scarce and heterogeneous 
reports 
 
Some National reports include information about emergency hospital visits after road traffic 
accidents due to the influence of drugs and/or alcohol. We reviewed the data on these accidents in 
the 2011 National reports (published in 2012) for all countries that had reported drug-related 
emergency episodes in their National reports since 2008. Only four countries reported data on 
drug-related traffic accidents (the Czech Republic, Hungary, Italy and the United Kingdom) in 2011 
— and Norway in 2009. However, the reports had many limitations. The reporting method was not 
standardised and data came from a variety of epidemiological approaches (e.g. prevalence of drug 
among severely injured or dead drivers, and roadside surveys). Some reports provided the number 
of accidents where illicit drug use was involved, but did not specify whether they were followed by 
an emergency hospital admission, and Italy and the United Kingdom did not specify which drug 
was involved. Therefore, no comparison should be made between countries, and any analysis 
should be cautious: the statistics from the National reports should not be used to estimate 
emergency episodes that follow road traffic accidents. Further information can be found in the 
EMCDDA report on drugs and driving (EMCDDA, 2012b) and a summary of this (including 
methods and the results on cocaine) is presented in Annex 3. 
 
 
5.6 Possible way forward and suggestions 
 
Despite the limitations discussed above, we believe that we have captured data from the countries 
that have the greatest number of cocaine-related hospital emergency cases, and that we have 
gone some way to identifying the burden of harm related to cocaine, the characteristics of the 
patients and the trends within each of these countries. 
 
Many European countries are able to monitor (at least to some extent) the morbidity associated 
with drug use (including the harms related to cocaine) using data from hospitals, particularly 
emergency departments. Although the implementation of a coherent system for monitoring drug-
related emergency consequences would have both practical and cost implications, our findings 
suggest that it constitutes an important indirect indicator of drug use.  
  
Some suggestions can be made to try to improve the usefulness of this data. There is a need for 
explicit case definition(s) of drug-related emergency episodes that are considered and reported. 
The reports from the monitoring systems need to specify in particular the settings, and the 
inclusion and exclusion criteria for the cases. This would allow the countries to reproduce easily 
the monitoring systems that have proved to be efficient and feasible in other countries and would 
constitute a step towards the harmonisation of the data produced by existing systems in Europe. It 
would ultimately improve the comparability between countries. This standardisation would also 
facilitate the continuity of the monitoring systems, which is currently not the case in all countries, as 
reports from some monitoring systems have been discontinued, impeding the analysis of trends. 
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6. Conclusions and public health implications 
 
This study has revealed a substantial increase in the number of cocaine-related episodes in 
several countries from the late 1990s until 2007–08. This trend is consistent with the trends in 
prevalence of use of cocaine in the general population and with the reported number of cocaine-
related deaths. This report documents the considerable morbidity related to cocaine use, translated 
into a large number of cases — several thousand every year — seen in various emergency 
settings in Europe. The cases are mainly young male adults who have used other drugs together 
with cocaine.  
 
This report reveals the considerable burden on emergency services in some countries in Europe 
that results from cocaine use. It points to the potential for early prevention, assessment and referral 
opportunities that may currently be overlooked. There is appreciable scope to intervene and to 
refer some patients from emergency departments to drug treatment services or psychosocial 
support: it has been argued that a closer link between emergency departments and addiction 
services would help to guide problematic cocaine users towards appropriate treatment at an earlier 
stage than currently (de Millas et al., 2010).  
 
Data on drug-related emergencies also have reasonable potential to report on the harms 
associated with patterns of drug use that are becoming more dominant and which are difficult to 
detect from other information sources. In particular, the data from emergency services may 
become increasingly important as stimulant use and polydrug consumption patterns become more 
common on the European drug scene.  
 
Other possible uses of this indicator include the detection of new psychoactive drugs in circulation 
and the implications of their use in emergency episodes. This might be feasible and relevant in 
areas where the prevalence of their use is relatively high (such as nightlife settings). The objectives 
of such studies focused on recreational drugs, and in particular on new drugs, vary from early 
warning systems to the monitoring of trends. Their feasibility depends on what data are recorded 
and available on the patients, and on the emergency episode. It also depends on comprehensive 
toxicological testing (which may require working with laboratories that are willing and able to carry 
out drug screening beyond the routine screening that is carried out in hospitals) (Dargan and 
Wood, 2009).  
 
More information on episodes related to recreational drugs seen in hospital emergency settings 
should be made available from the European Commission funded Euro-DEN project, which began 
in 2013 and runs for two years. Euro-DEN involves 11 countries (the Czech Republic, Denmark, 
Estonia, France, Germany, Ireland, Poland, Spain (Barcelona and Mallorca), the UK, Norway and 
Switzerland) and will be collecting data from hospital emergency departments in these countries on 
presentation to hospital with acute ‘recreational drug’ toxicity. It aims to identify potential 
differences in the drugs responsible for toxicity across Europe, trends in presentations over time 
and trends in presentations related to new psychoactive substances (European Commission, 
2012). Other European Union funded projects may follow the new call for proposal launched in 
2013 (European Commission, 2013). Under the priority of prevention, projects were called to 
develop approaches towards the systematic collection of data on emergency room admission 
relating to drugs, with a particular focus on identifying trends in use and adverse consequences 
relating to stimulant and poly drug use. 
 
Results of enhanced surveillance of emergency settings could also contribute to further monitoring 
the increasing harms associated with the non-medical use of prescription drugs, particularly 
prescription opioids and benzodiazepines. Recent data also points to the need to monitor closely 
any increase in deaths caused by opioid analgesics as it may signal an emerging problem in 
Europe similar to the issue that is now well established in the US (Giraudon et al., 2013). 
Monitoring the non-fatal intoxications and emergencies related to prescription drugs would 
contribute to detecting and assessing this increasing European public health concern. Investment 
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in this area could provide an indicator of drug use trends, help monitor the consequences of drug 
use within Europe and measure hospital emergency departments’ drug-related workload.  
 
Among the emergency settings identified in this report, poison information centres could be further 
used as source of information on drug use (including NPS) and its health consequences. Use of 
this source was reported only from Belgium and the Netherlands, but there may be similar centres 
in many other countries.  
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Annex 1: Data collection sources and results, country by country 
 
Belgium  
 
National reports 2007–10 
The National Poison Centre Belgium received 337 calls from health professionals and the general 
public regarding drug intoxications during 2010. Eighteen (5.3 %) were related to cocaine and 
another 124 concerned polydrug use, some of which involved cocaine. There were 312 calls in 
2008, of which 19 (6 %) involved cocaine. Fewer calls (299) were received in 2009, of which 24 
(8 %) related to cocaine.  
 
The Minimal Psychiatric Data (MPD) is a registration system run by the Belgian Federal Public 
Service, Health, Food Chain Safety, and Environment, collecting data at every psychiatric inpatient 
admission. Diagnostic data are collected based on the Diagnostic and Statistical Manual of Mental 
Disorders (DSM-IV; APA, 2000) shortly after patients’ admission. The MPD system explicitly 
requests the main diagnosis leading to the admission. 
  
Among all psychiatric admissions in 2008 for which a substance-related disorder was reported by 
the MPD, the most frequently diagnosed psychiatric co-morbidities were personality disorders 
(41 %), substance-related disorders due to illicit drugs other than opiates, cocaine, stimulants, 
cannabis and hypnotics (27.3 %), psychotic disorders (17.4 %) and alcohol-related disorders 
(7.8 %). Cocaine was recorded as the reason for 740 of 5 289 (14.0 %) admissions due to a 
unique substance. Furthermore, cocaine was involved in one-third of the 2 253 polydrug cases. In 
total, 1 483 of 9 142 (16.2 %) admissions were related to cocaine. Roughly half of these cases 
were related to cocaine alone and the other half were related to cocaine associated with other 
drugs. Among cocaine users, the most prevalent co-morbidity was personality disorder (diagnosed 
in 40.5 % of those in which cocaine was the only drug involved). 
 
Most recent data (from the 2011 National report) 
There was a slight increase in the overall number of calls to the National Poison Centre in 2011 
(346). Sixteen (4.6 %) of them were related to cocaine, almost equal to the number in 2010. 
Another 114 cases concerned polydrug use, some of them also involving cocaine. 
 
There was no update of the cocaine data available from the MPD for 2008. 
 
The 2011 National report refers to data from the DRUID project (EMCDDA, 2012b): 0.8 % of the 
1 078 injured drivers who were admitted to an emergency department participating in the study 
between January 2008 and May 2010 tested positive for cocaine (0.1 % for cocaine alone). A total 
of 37 % were tested positive for one or more substances, including alcohol. 
 
Bulgaria 
 
National reports 2007–10 
In 2010 a total of 152 drug-dependent persons required emergency medical aid at the Clinic of 
Toxicology of the Multiprofile Hospital for Active Treatment and Emergency Medicine (MHATEM) 
‘Nikolaj Ivanovich Pirogov’ because of acute poisoning, representing 2 % of all the patients 
registered at the admission toxicology surgery for 2010 (the corresponding proportion for 2008 was 
1.8 %). This was the smallest number of drug dependent patients at the clinic during 2008–10 (159 
in 2008 and 194 in 2009). Over half (57 %) of those attending in 2010 were treated as outpatients 
in the emergency admission ward. The majority of episodes were related to heroin (45 %), followed 
by cannabis (26 %), amphetamines (23 %) and cocaine (7 %, or 11 episodes).  
 
There were more male than female patients every year (129:30 in 2008, 160:34 in 2009, and 
113:39 in 2010), although the proportion of males decreased to 74.3 % in 2010 from 81 % in 2008 
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and from 82 % in 2009. Most (80 %) were aged 19–35 (75 % were in this age group in 2008, and 
73 % in 2009).  
 
Data from the Ministry of Health report 3 127 non-fatal drug-related emergencies in 2010, of which 
1 116 were overdoses and 2 011 were other non-fatal drug-related emergencies. Regional data for 
Sofia (981 cases) suggest that two-thirds of the episodes were related to withdrawal syndrome, 
and 17 % to overdose. The remainder were classified as ‘other non-fatal cases’. No specific data 
on cocaine-related emergencies are available, as individual substances are not identified. 
 
In 2009 the ministry reported 1 583 drug-related emergencies but only 11 of 28 centres for 
Emergency Medical Aid (CEMA) had provided information. Therefore, the data for 2009 and 2010 
are not comparable and do not allow the identification of trends.  
 
Most recent data (from the 2011 National report) 
According to the MHATEM ‘Nikolaj Ivanovich Pirogov’, in 2011 there was an increase in the 
number and proportion of cocaine related cases (12 % or 30 episodes in 2011, compared with 7 % 
or 11 episodes in 2010).  
 
 
Czech Republic 
 
DRD expert response to questionnaire  
Data on cocaine-related emergencies are collected from hospital emergency departments 
nationwide, but in practice there are substantial regional differences in coverage. Various health 
facilities, primarily emergency units, provide reports to the system. It would be possible to obtain 
access to hospital discharge diagnostic codes for emergency visits. 
 
There are no research studies of illicit drug-related hospital emergency visits in the Czech 
Republic.  
 
National reports 2007–10 
A sentinel-type system (an early-warning and monitoring system) of data collection has been 
operated by the Public Health Service since 1995, and the data are collected centrally by the 
Public Health Office in Prague. In 2010 there were 849 reported cases of non-fatal intoxication with 
drugs, continuing a decreasing trend (1 255 in 2007; 1 146 in 2008; 1 018 in 2009). No cases 
involving cocaine were reported in 2010, although there were seven cases in 2008 and two in 
2009.  
 
Most recent data (from the 2011 National report) 
The most recent data show a continuing decrease in the reported number of cases of non-fatal 
overdoses with drugs, with 805 cases recorded in 2011, of which one involved cocaine. As in 
previous years, the most common substances named as causing these were pervitin (150 cases in 
2011), benzodiazepines (138 cases) and other sedatives and hypnotics (105 cases). In 2011 
problems with reporting persisted in Prague and in other regions, which did not report a single case 
for that year. This suggests an underestimation of the number of emergency episodes related to 
drugs.  
 
In 2011 information on the occurrence of intoxication with addictive substances from 2002 to 2011 
was collected for the first time from the National Register of Hospitalisations (NRHOSP) and 
managed by the Institute of Health Information and Statistics (only cases requiring hospitalisation 
for more than 24 hours are reported to this register). There has been a long-term decline in the 
number of admissions for drug poisoning with illicit drugs, from 375 in 2002 to 232 in 2011. In 2011 
cocaine was present in one case. 
 
In 2011 a total of 781 individuals underwent an autopsy following their death in a road traffic 
accident. Of these, 397 had a toxicological examination and cocaine was not identified in any case. 
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Denmark 
 
DRD expert response to questionnaire 
Data from the Landspatientregistret or National Patient Register (LPR) include patients registered 
in somatic or psychiatric emergency departments with poisoning as the main diagnosis, and also 
those who have been hospitalised with poisoning symptoms without first being in contact with an 
emergency department.  
 
The episodes recorded include those related to heroin, other opioids, methadone, ecstasy, 
amphetamines, cocaine, other stimulants and cannabis. From 2000, the coding was altered to 
record poisoning with amphetamines and with khat. 
 
National reports 2007–10 
In Denmark the number of individuals admitted to emergency wards as a result of poisoning with 
illicit drugs has been rising steadily since 2005. From 1999–2010 between 1 147 and 1 868 people 
were registered annually, and although the number was stable between 1999 and 2005, in 2010 it 
had increased by 50 % from 2005. It should be noted that the 2010 data were retrieved in August 
2011, whereas the data for the previous years had usually been retrieved in May or June. This 
might have contributed to the increase in 2010. The increase from 2009 to 2010 was particularly 
due to opioids other than heroin, and to stimulants, especially amphetamines and cocaine.  
 
In 2009, of a total of 1 662 cases of poisoning, 140 (8.4 %) were related to cocaine, a similar 
proportion to those reported in 2010 (155, or 8.3 % of a total of 1 868). Most cases of poisoning 
were caused by opioids used by people aged 30 and over. Overall, the proportion of cases aged 
30 and over has increased compared with 2005, from around 45 % (of 1 147 cases) in 2005 to 
around 55 % (of 1 660 cases) in 2010. Poisonings caused by stimulants are most frequently seen 
among young people (aged under 24) although 30 % of cocaine poisonings occurred among those 
aged 30 and over.  
 
In 2010 a total of 5 031 people were admitted to psychiatric hospitals with a drug-related primary or 
secondary diagnosis (co-morbidity). This is fewer than in 2009 (5 464 persons). The decline 
appears after a linear increase in the number of persons admitted to psychiatric hospitals with a 
secondary drug-related diagnosis: 3 718 in 2009 and 3 445 in 2010. Those with a drug-related 
primary diagnosis totalled 1 536 in 2008; 1 746 in 2009; and 1 586 in 2010. Over the past 10 years 
those with primary diagnoses related to polydrug use have comprised the largest group.  
 
Figure 1 shows the number of hospital contacts due to intoxications and poisoning caused by 
cocaine over a 13-year period. 
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Figure 1 
Patients registered at emergency departments in Denmark due to 
intoxications and poisonings caused by cocaine, 1999–2011. 
  
Sources:  
Reitox National Focal Point, Denmark (2012), National report 2011: Denmark, European 
Monitoring Centre for Drugs and Drug Addiction, Lisbon 
(www.emcdda.europa.eu/html.cfm/index213824EN.html) 
EMCDDA (2013c), Perspectives on drugs: emergency health consequences of cocaine use in 
Europe, European Monitoring Centre for Drugs and Drug Addiction, Lisbon. 
(www.emcdda.europa.eu/topics/pods/cocaine-related-emergencies). 
  
0
50
100
150
200
1999 2001 2003 2005 2007 2009 2011
  
40
Most recent data (from the 2011 National report) 
The number of cocaine-related emergency cases reported in 2011 remained stable compared with 
2010: 155 (8.3 %) of 1 868 in 2010 and 150 (8 %) of 1 880 in 2011. Overall, two-thirds (66 %) of 
the drug-related cases were male. A large majority (90 %) of all cases were treated in somatic 
emergency wards and the others were treated in psychiatric emergency wards. These details were 
not available for cocaine users, however. 
 
Stimulant users were younger compared to other groups of drug users. The most common age 
band for stimulant-related cases (including cocaine) was 20–24, whereas the cases related to 
opioid and to polydrug use were aged 30 and older. As in previous years, it is assumed that drug 
poisonings are underreported. 
 
 
Germany 
 
National reports 2007–10 
The only recent data on non-fatal overdoses in Germany are from the Monitoring-System 
Drogentrends (MoSyD) study of the Frankfurt scene (Mueller et al., 2011). The study was 
conducted from 2002 to 2010, with cross-sectional interviews every second year. Almost two-thirds 
(293, or 64 %) of the drug users had survived an overdose at least once. The median number of 
overdoses was 2.5, and on average the last overdose occurred three years previously.  
 
When asked about the drug(s) that had been used at the time of the last overdose in 2010, heroin 
was cited most frequently (by 94 %), followed by crack cocaine (40 %), medications — particularly 
benzodiazepines (34 %), alcohol (26 %) and cocaine (13 %). The proportion of cases related to 
cocaine has decreased compared with 2008 (25 % in 2008 and 13 % in 2010), whereas the 
proportion of cases related to crack has been stable (38 % in 2008 and 40 % in 2010). When 
asked about the substance that was primarily responsible for the overdose, heroin was cited most 
often (by 47 %), followed by the simultaneous use of several substances (26 %).  
 
The main reason given for the overdose was mainly the unknown quality of the drugs used (47 %), 
followed by polydrug use (26 %). One-eighth of those who had overdosed said it was because they 
had used too much after a period of abstinence. Other reasons, such as being in poor health or the 
intention to commit suicide, were infrequently given.  
 
The consumption room was the most frequently reported setting for overdose (by 57 %), followed 
by on the street (21 %) and at home or in other private settings (19 %).  
 
Sixty per cent of respondents had received help from drug services when they overdosed, 36 % 
from emergency doctors, 13 % from other drug users, 6 % from acquaintances (non drug users) 
and a further 6 % stated that they had not received any help at all. 
 
Most recent data (from the 2011 National report) 
The most recent data do not correlate with the study previously referred to, making it impossible to 
comment on trends. 
 
 
 
Estonia 
 
National reports 2007–10 
Relevant data are limited to Tallinn. According to the Tallinn Ambulance Service, drug users were 
provided with emergency healthcare due to an overdose on 930 occasions in 2010, of which 75 
resulted in hospitalisation. In 2009 emergency healthcare for overdose was provided on 1 399 
occasions. In comparison with previous years, the number of drug overdoses decreased 
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dramatically in 2010 (1 308 in 2007; 1 225 in 2008; 1 399 in 2009). No specific data on cocaine-
related emergencies are available. 
 
Most recent data (from the 2011 National report) 
Compared with 2010, there was a slight increase in the number of overdose cases reported by the 
Tallin Ambulance Service in 2011 (952 cases, 84 of which resulted in hospitalisation). Again, no 
specific data on cocaine-related emergencies are available. 
 
 
Ireland 
 
DRD expert response to questionnaire 
There is no national data collection system recording those attending hospital emergency 
departments only. If persons are admitted to and discharged from hospital, they are entered onto 
the Hospital In-Patient Enquiry system (further details below). The National Drug-Related Deaths 
Index (NDRDI) receives an electronic download of information on discharges relating to drug users 
who die when they are a hospital inpatient. If a person dies of an unnatural cause (such an illicit 
drug overdose) in an emergency department, the death comes under the remit of the coroner and 
is also recorded by the NDRDI. It would not be possible to obtain access to hospital discharge 
diagnostic codes for emergency visits. 
 
There are two relevant publications on illicit drug-related hospital emergency visits in Ireland: 
Kelleher (2007) and Kelleher and Cotter (2009), both concerning emergency doctors’ and nurses’ 
knowledge of and attitudes to substance use and users.  
 
National reports 2007–10 
HIPE (Hospital In-Patient Enquiry) is a computer-based health information system, managed by 
the Economic and Social Research Institute (ESRI) in association with the Department of Health 
and Children (DoHC) and the Health Service Executive (HSE). It collects demographic, medical 
and administrative data on all admissions, discharges and deaths from acute general hospitals in 
Ireland. It was started on a pilot basis in 1969 and then expanded and developed as a national 
database of coded discharge summaries from the 1970s onwards. Each HIPE discharge record 
represents one episode of care: each discharge of a patient, whether from the same or a different 
hospital, or with the same or a different diagnosis, generates a separate HIPE record. The scheme 
therefore facilitates analyses of hospital activity rather than of the incidence of ill health.  
 
Data extracted from HIPE in 2009 reveal that there were 4 202 overdose cases, of which 30 
resulted in death in hospital (0.7 %), the other 4 172 cases being discharged. Of the discharges, 
the number of overdose cases decreased by 2.9 % between 2007 and 2008, and by 13 % between 
2008 (4 772) and 2009.  
 
During 2005–09, there were more overdose cases among females than among males: females 
accounted for 54 % of all overdose cases in 2009. In the four-year period 2005–08 one-quarter of 
overdoses occurred in persons aged 15–24 years, with the incidence of overdose decreasing with 
age. The proportion of under-25s who overdosed fell in 2009, accounting for 32 % (1 328 of 4 172 
discharges), compared with 40 % (2 015 of 5 012 discharges) in 2005.  
 
In 2009 HIPE data reveal 92 overdoses involving cocaine (2.1 % of 4 172 discharged overdose 
cases). This is a decrease compared with 121 of 4 918 discharges in 2007 (2.5 %) and 131 of 
4 772 discharges in 2008 (2.7 %). 
  
Most recent data (from the 2011 National report) 
In 2010 the HIPE data were stable compared with the previous year, with a total of 94 overdoses 
involving cocaine and discharged from hospitals (2.1 % of 4 522 cases). Cocaine represented 
16 % of the 588 cases that involved narcotics and hallucinogens, far less common than opiates 
(80 % of these cases). Overall, the proportion of under-25s who overdosed was stable in 2010 
(34 %) compared with 2009 (32 %), but these data were not available for cases related to cocaine.  
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Spain 
 
DRD expert response to questionnaire 
Data to monitor hospital emergencies related to the non-medical or non-therapeutic use of 
psychoactive drugs in Spain began to be collected in 1987 and comprised part of a broader range 
of information sub-systems developed within the framework of the National Plan on Drugs in 
collaboration with the Autonomous Communities.  
 
National reports 2007–10 
Data collection on drug-related hospital emergencies includes the date of the emergency, gender, 
age, nationality, the patient's legal status (whether or not they are under arrest), detailed diagnoses 
of the emergency, psychoactive substances (up to six) used, routes of administration, evidence of 
the emergency being directly related to the drugs used and the most recent route of administration, 
and the treatment provided for the emergency. 
 
The data are used to monitor the evolution and characteristics of problem psychoactive drug use, 
especially opiates and cocaine, which usually cause more frequent problems than other drugs. 
Unlike the treatment admissions indicator, this indicator has never been implemented in all of the 
Autonomous Communities and, with some exceptions, the areas covered and the number of 
hospitals that are monitored in each have varied from year to year. In addition, the system 
underwent some major definitional changes in 1996 and 2003. With this history, the national 
perspective presented below must be treated with caution.  
 
During 2009 a total of 11 890 emergency episodes involved those who had used non-therapeutic 
or non-medical psychoactive drugs (whether or not use was the reason for the visit to emergency 
services). The information came from 15 Autonomous Communities, in most areas confined to one 
randomly selected week per month, while in others, such as in the city of Barcelona or on the 
Island of Ibiza, data were generated continuously. Of these episodes, 5 567 (46.8 %) were related 
to the non-therapeutic use of psychoactive drugs, whether the drug was mentioned or directly 
related to the episode (compared with 7 838 in 2007 and 6 431 in 2008). In 2009: 
 
• Most patients were male (77.3 %). The percentage of females has varied across the years, 
ranging from 20.8 % in 1997 to 28.0 % in 2004.  
 
• The average age of the emergency department patients was 32.7, and the male average 
was older than the female average. Over the years, the general trend has been an increase 
in the age of patients, from an average of 27.8 in 1996 to 32.4 in 2008.  
 
• The youngest cases related to volatile inhalable drugs (average 24.6 years), hallucinogens 
(average 27 years) and ecstasy (average 28.6 years). The oldest average age was in 
cases with mentions of heroin (36.2 years) or other opiates (37.8 years). The average age 
of those with cocaine involved was 33.4 years.  
 
• The outcome of the 3 413 cases related to cocaine was mainly discharge (81.2 %), self-
discharge (8.7 %), hospital admission (7.5 %) and transfer to another hospital (2.5 %). 
 
• In 2009, of all 5 567 episodes related to drugs (whether the drug was mentioned or directly 
related to the episode), cocaine was the most commonly mentioned substance, reported by 
61.3 % of emergency department patients. These episodes included the cases for which 
regular or sporadic use of cocaine was noted in the medical records, and episodes where 
cocaine was directly related to the emergency problem. The proportion of patients who had 
used cocaine rose from 27.4 % in 1996 to 63.4 % in 2005, but has stabilised at 60–63 % 
since then. Cocaine was also the drug most often mentioned as directly related to the 
emergency problem (in 51.1 % of cases). 
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• Of the emergency cases where the physician stated a direct relationship between drugs 
and the emergency episode, the average age was 32.9 years (33.4 years for cocaine), and 
79.5 % (79.6 % for cocaine) were males. 
 
• The most frequent administration route, reported by 60.0 % of cases where cocaine was 
directly related to the emergency, was intranasal (sniffing or snorting), followed by injection 
(18.3 %) and smoking (17.4 %).  
 
Figure 2 shows the number of drug-related emergencies 1999–2011 that were directly related to 
cocaine use.  
 
Figure 2 
Emergency cases due to an acute reaction following the use of 
psychoactive substances with a direct relation to cocaine in Spain, 
1999–2011. 
 
 
  
Sources:  
Reitox National Focal Point, Spain (2012), National report 2011: Spain, European Monitoring 
Centre for Drugs and Drug Addiction, Lisbon 
(www.emcdda.europa.eu/html.cfm/index214091EN.html). 
EMCDDA (2013c), Perspectives on drugs: emergency health consequences of cocaine use in 
Europe, European Monitoring Centre for Drugs and Drug Addiction, Lisbon. 
(www.emcdda.europa.eu/topics/pods/cocaine-related-emergencies). 
 
Most recent data (from the 2011 National report) 
The most recent data on cocaine-related emergencies confirmed the decreasing trend observed 
from 2008. In 2010, of all episodes related to drugs, cocaine was the most commonly used, 
reported by 58.5 % of emergency department patients. Cocaine was also the drug most frequently 
directly related to the emergency problem, in 2 779 of 5 626 cases (49.4 %). In 2011 this number 
had decreased again, down to 2 386 cases (communication of the 2011 total number by the 
Spanish National Focal Point with no further breakdown, mentioned in the revision of Perspectives 
on drugs, dated 10 June 2013). 
 
In 2010 the age distribution of the cases where cocaine was directly related to the emergency was 
stable compared with previous year, with patients aged 33 on average and aged 33.3 for those 
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where cocaine was among the substances mentioned. The proportion of female cases in which 
cocaine was directly related to the emergency increased from 20.4 % in 2009 to 25.5 % in 2010. 
The increased proportion of females was also observed for other drugs.  
 
The main route of administration of cocaine by patients seen at emergency services in 2010 was 
intranasal, and the proportion of patients who had used this route slightly increased from 2009. The 
most frequent administration route for cases in which cocaine was directly related to the 
emergency was also intranasal (63.4 %, compared with 60.0 % in the previous year) followed by 
injection (16.3 %) and smoking (15.5 %).  
 
 
France 
 
National reports 2007–10 
The ENa-CAARUD (Centres d´accueil et d´accompagnement à la réduction des risques pour 
usagers de drogues) national survey is conducted every two years (Chalumeau, 2010). Of the drug 
users interviewed in 2008 a total of 7.4 % (224) reported having had an episode of loss of 
consciousness after taking psychoactive substances in the previous twelve months. Where the 
information was available, the substances that 211 of these users most commonly presumed to be 
responsible for this were heroin (21.3 %), alcohol (19.0 %), and cocaine (18.5 %). 
 
Most recent data (from the 2011 National report) 
The most recent data are similar to those from 2009. In 2010 a total of 6.5 % (144) of the ENa-
CAARUD users reported having had an episode of loss of consciousness after taking psychoactive 
substances in the previous twelve months. Where the information was available, the substances 
most commonly reported by users to be responsible for this were heroin (23.6 % of cases) and 
cocaine (18.8 %). Alcohol (13.9 %) showed a decrease. 
 
 
Italy 
 
According to the Italian Ministry of Health, nationally, the number of hospital admissions with 
principal or secondary diagnoses related to psychoactive drug use was 26 601 in 2007; 25 910 in 
2008; and 23 997 in 2009. These cases represented around two per thousand of all annual 
hospital admissions, for each of these three years. There was a 10 % decrease over the three-year 
period in question, a greater decrease than that observed overall for admissions related to all 
causes. 
 
In 2009 the average age of the drug-related cases was 40 years for men (46 years for women) and 
58 % were male. 
 
The most frequent outcome of cases in 2009 was discharge to home, for around eight in ten cases, 
followed by self-discharge for around one in ten. The other cases were transferred to another 
facility and less than 1 % died. Around one-third of these hospital admissions were related to non-
urgent or planned care, whereas two-thirds were urgent and required emergency care: 15 445 
cases in 2008 and 14 470 in 2009.  
 
Cocaine was the cause of the admission in 2 408 cases in 2008, compared with 1 898 cases in 
2009 (a 21.2 % decrease). The proportion of hospital admissions accounted for by cocaine has 
increased from 2004 to 2008, when it reached a peak with 9.3 % of the admission related to drugs. 
It decreased afterward and cocaine represented 7.9 % of all the drug-related admissions in 2009. 
 
Most recent data (from the 2011 National report) 
The data presented above were not updated in the most recent National report, although there is 
some analysis of the mortality of patients admitted to hospital for drug-related causes. 
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In 2010 a total of 208 people died after a drug-related admission, representing less than 1 % of the 
total number of drug-related admissions during that year. A third of the hospital admissions related 
to opiates ended in deaths (32 %), compared with 6 % of those related to cocaine.  
 
Between 2008 and 2010 the number of drug-related hospital admissions fell by 7.8 %. Over this 
period, drug-related hospital admissions represented two per thousand of all hospital admissions 
and were mostly related to psychiatric problems, traumas and poisoning. Medical emergencies 
accounted for most of these admissions. There was no information on how many of the admissions 
followed cocaine-related episodes. 
 
The National Institute of Statistics reported 211 404 road traffic accidents in 2010 in which persons 
were injured or killed, a decrease of 1.9 % compared with 2009. In the course of these accidents, 
302 735 persons were injured and 4 090 died. Drugs were the cause in 0.43 % (916) cases; in 
0.49 % (1 471) of the injuries; and in 1.47 % (60) of the deaths. There was no information on the 
specific substances involved.  
 
 
Cyprus 
 
DRD expert response to questionnaire 
A large percentage of drug users are treated for overdose at hospital emergency units. However, 
there is a scarcity of resources at such units for recording non-fatal overdoses and drug-related 
fatal poisoning, injury, and acute health episodes. 
 
National reports 2007–10 
Only basic information was collected from four of the country’s five hospital emergency units. Four 
cocaine-related cases were reported in 2010, and nine in 2009. 
 
During 2009, in order to determine the profile of overdose patients presenting at hospital 
emergency departments, representatives of hospital emergency units that participate in the Special 
Registry’s working group were given precise instructions on how to improve reporting non-fatal 
illicit drug-related emergencies. Currently, some sporadic recording of cases does take place and 
some relevant training of hospital emergency department staff has also been conducted. Although 
they have repeatedly asserted that it will be very difficult to collect information, emergency unit 
representatives have nevertheless expressed a commitment to doing so.  
 
Most recent data (from the 2011 National report) 
In 2011, basic information was requested from all five of the country’s hospital emergency units. 
Four cases of non-fatal overdose were reported by two hospitals. Two hospitals did not collect 
information, and one mentioned only ‘many cases of known drug users’. Due to a lack of human 
resources, the recording of information continues to be scarce. There was no information available 
specifically on emergencies related to cocaine.  
 
 
Latvia 
 
DRD expert response to questionnaire 
The Latvian National Focal Point does not currently have data from hospital emergency 
departments, although work is planned with them to collect data on those receiving assistance in 
drug overdose cases. 
 
National reports 2007–10 
At the Riga Eastern Clinical University Hospital Toxicology Centre, 186 overdoses due to illicit 
drugs were registered in 2007 and 143 in 2009. These cases are limited to inhabitants from Riga 
and the Riga district. There were two cases of cocaine overdose in 2007 (1 % of all overdoses) 
and one in 2009 (0.7 %). No data were available for 2008. 
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Most recent data (from the 2011 National report) 
Data on non-fatal overdoses and on drug-related emergencies are still not compiled nationally. 
According to the information provided by the Riga Eastern Clinical University Hospital Toxicology 
Centre, the number of overdose cases has decreased compared with the 143 cases in 2009: there 
were 46 cases in 2010 and 61 in 2011.  
 
In 2011 the average age of the persons treated was 25 years, and 80 % were males. The number 
of cases in which cocaine was identified is not available. 
 
 
Lithuania 
 
DRD expert response to questionnaire 
National data are routinely collected by the State Patients’ Fund at the Ministry of Health and the 
Lithuanian National Focal Point reports on drug-related poisoning. It would be possible to obtain 
access to hospital discharge diagnostic codes for emergency visits. 
 
National reports 2007–10 
In 2010, according to the State Patients’ Fund, healthcare institutions recorded fewer cases of 
poisoning with drugs than in the previous four years. There were 255 cases in 2010 compared with 
308 in 2009. Opioids (opium, heroin, codeine, morphine or methadone) were involved in 130 cases 
(51 %) in 2010 compared with 124 (40 % of 308 cases) in 2009.  
 
Of these cases, the proportion with heavy intoxications (defined as those who required referral to 
intensive care units) increased. In 2010 emergency hospitals reported 127 such episodes involving 
117 individuals. Heavy intoxication episodes accounted for 50 % of all cases of drug intoxication. 
This compares with 75 episodes involving 68 persons in 2009 and 118 episodes involving 106 
persons in 2008.  
 
During the five years from 2006–10 a total of 8.9 % (127 of 1 423) of intoxications involved 
cocaine.  
 
In 2010 there were four times more males than females registered as hospital inpatients due to 
poisoning with drugs and psychotropic substances: 204 males (191 in 2009) and 51 females (47 in 
2009). Fourteen (5.5 %) of these 255 cases were attributed to cocaine (11 males and 3 females). 
 
Most recent data (from the 2011 National report) 
In 2011 there was a significant decrease in the total number of poisonings with drugs: 211 cases 
and 181 individuals compared with 255 cases and 238 individuals in 2010. The average age of the 
patients was 28.6 years and the majority (140/181; 77 %) were males. The drugs most often 
involved were opium (53 cases) and heroin (41 cases). The proportion of heavy intoxication 
episodes decreased from 127 of 255 (50 %) in 2010 to 78 of 211 (37 %) in 2011. Cocaine 
accounted for 9 % (19 of 211) of cases in 2011, a slight increase compared with 6 % (14 of 255) of 
cases in 2010.  
 
 
Hungary 
 
DRD expert response to questionnaire 
There is no routine national data collection system on drug-related visits to hospital emergency 
departments in Hungary. However, the Clinical Toxicology Department of Péterfy Sándor Street 
Hospital in the Municipality of Budapest reports to the Országos Statisztikai Adatgyűjtő Program 
(OSAP, the National Statistical Data Collection Programme) which includes national data on drug-
related treatment. Since all drug-related intoxications are treated in this department and clients 
from Pest county are also brought here, the system can be categorised as a regional data 
collection system.  
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It would be possible to obtain access to hospital discharge diagnostic codes for emergency visits, 
from the National Health Insurance Fund.  
 
There are no studies of illicit drug-related hospital emergency visits in Hungary.  
 
National reports 2007–2010 
During 2010 a total of 1 962 people were treated at the Clinical Toxicology Department of Péterfy 
Sándor Street Hospital due to illicit drugs or organic solvents (670 in 2006; 672 in 2007; 1 692 in 
2008; 1 808 in 2009). There was therefore an increase of 8.5 % from 2009 to 2010.  
 
There was a slight increase in the number of males who were treated in 2010 (1 042 in 2009 and 
1 111 in 2010) and an 11 % increase in the number of females (766 in 2009 and 851 in 2010). The 
age groups 20–24, 25–29 and 30–34 were the most represented in 2010 (respectively 209, 246, 
221 male cases and 141, 122, 137 female cases).  
 
The number of people treated in 2010 due to cocaine use did not change much compared with the 
previous year (67 people compared with 64 in 2009), but there was a 26 % increase between 2008 
(53 persons) and 2010.  
 
Most recent data (from the 2011 National report) 
In 2011 there was a significant increase in the number of people who were treated at the Clinical 
Toxicology Department of Péterfy Sándor Street Hospital due to illicit drugs or organic solvents: 
2 662 cases compared with 1 962 in 2010 — a 36 % increase. The increase was larger among 
males (+ 59 %) and was mainly accounted for by episodes related to ‘amphetamine-type 
stimulants (ATS)’ (+86 %). About two-thirds of all cases were related to ATS (61 %). No more data 
are available on the nature of the drugs classified in this group but it is suggested than many could 
be due to the increasing use of cathinones. 
 
In 2011 a total of 22 people were treated due to cocaine, a decrease from 67 compared with the 
previous year.  
 
In 2011 some 132 cases of road traffic accidents were suspected to be related to drugs. The 
Institute of Toxicology screened urine samples for drugs and 87 were positive. The most common 
substances identified were THC (23 cases), benzodiazepines (16 cases) a combination of THC 
and amphetamines (11) and amphetamine alone (7). Two cases were positives for cocaine alone 
and 7 cases were positive for a combination of cocaine and THC. 
 
 
Malta 
 
National reports 2007–10 
Data on non-fatal overdoses are obtained on a yearly basis from police drug squad records. There 
were 65 cases of non-fatal overdoses related to illicit drugs in 2009, representing 29 % of all 
overdose cases, and 59 cases in 2010 (26 % of all overdose cases). Although there was a small 
decrease in the number of cases from 2009 to 2010, there was an overall substantial increase 
compared with previous reporting years, with only 19 cases reported in 2007 (20 % of all 
overdoses) and 28 cases in 2008 (27 %). The vast majority (88 %) of non-fatal overdose cases 
related to illicit drug use were male.  
 
No specific data on cocaine-related emergencies are available. 
 
Most recent data (from the 2011 National report) 
Police drug squad records showed a decrease in non-fatal overdoses in 2011, with 42 cases 
related to illicit drugs compared with 59 in 2010. Cases related to illicit drugs represented 25 % of 
all overdose cases, similar to the proportion in 2010 (26 %). No specific data on cocaine-related 
emergencies are available. 
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Netherlands 
 
National reports 2007–10 
There are five relevant data collection systems in the Netherlands: Monitor Drugs Incidenten (MDI), 
a monitor of drug-related emergencies; ambulance transportation data in Amsterdam; Letsel 
Informatie Systeem (LIS), a drug-related emergencies monitor covering several regions of the 
country; requests for information on drug intoxications at the National Poison Information Centre 
(NVIC); and data from the National Drug Monitor on hospital admissions due to drug use or 
dependence (as a primary or secondary diagnosis). Data from each of these sources is presented 
below. 
 
Monitor Drugs Incidenten (MDI)  
MDI has been running since 2009. In eight sentinel regions in the country, data on emergencies 
related to drug use are collected in a standardised format at the emergency department of the 
hospital, at the ambulance and by forensic doctors (in the pilot phase, GPs were found to be not an 
informative source as they rarely saw these cases). In addition, several first aid organisations 
serving at large parties contribute to the monitor. These four sources deliver very different types of 
drug emergencies, and therefore contribute to providing a complete picture. The regions have not 
been selected for being representative but for being the most informative. Amsterdam is included 
as highly atypical, both in the types of drugs used (e.g. magic mushrooms are only used here) and 
in the atypical population seeking help, of which almost half are tourists. Also included are: a 
typical student city; a fisherman’s region with high reported cocaine use;; a border region; the 
region where GHB first came up, etc. It is thought that using sentinel regions instead of 
representative regions, allows new developments to be picked up earlier. The MDI system does 
not aim to produce national estimates of drug-related emergencies (8).  
Since 2009 data on drug-related emergencies at dance events and other setting mentioned above 
have been collected by the MDI from eight regions. The number of participating regions increased 
from four in 2009 to six in 2010. Cases are reported by the police, ambulance transportation 
services, hospitals and two first aid organisations at dance parties. Reported incidents totalled 
2 525 in 2009 and 2 852 in 2010. Two-thirds of the emergencies involved males and 39 % involved 
young adults aged 18–24.  
 
Cocaine alone was involved in 188 episodes in 2010 — 7 % of the total number of emergencies 
(11 % in 2009). In terms of cases involving the use of a single drug, cocaine was in fourth place, 
after cannabis (29 %), ecstasy (20 %) and gamma-hydroxybutyric acid (GHB, 13 %). The 
intoxications related to cocaine-only use were mostly categorised as ‘light’ or ‘mild’ (87 %). Males 
accounted for 79 % of incidents related to cocaine-only use and their median age was 31. Of the 
cocaine-related emergencies, 67 % also involved alcohol.  
 
Amsterdam ambulance transportation data  
The Public Health Service of Amsterdam (GGD Amsterdam) provides trend data on non-fatal 
emergencies brought to its attention by the Central Post for Ambulance Transports (CPA). The link 
between the emergency and drug use is based on case history and circumstantial data: there is no 
toxicological confirmation.  
 
The annual number of drug-related requests for emergency assistance by the CPA almost doubled 
from 2001 to 2010 (from 703 to 1 306). In 2010 most drug-related emergencies were related to the 
use of cannabis (45 %), followed by GHB and cocaine (130 cases, 10 % each). Two-thirds (67 %) 
of the cocaine-related cases required transportation to hospital (a proxy measure for the 
seriousness of the emergency), compared with 39 % of cannabis cases and 85 % of GHB cases. 
Although there was a small increase of the total number of cases requiring assistance in 2010, 
                                               
(8) This background information on the MDI system was provided by Esther Croes from the Trimbos-instituut. 
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cocaine intoxications decreased compared with the previous year, from 13.2 % (144 of a total of 
1 095 intoxications) in 2009 to 10.0 % (130 of 1 306). 
 
Letsel Informatie Systeem (LIS) data  
LIS, of the Consumer Safety Institute, provides information on the number of people treated 
annually at the emergency departments of hospitals. These data are derived from a representative 
selection of hospitals and extrapolated to yield national estimates. Because of the estimation 
method and associated error margin, data are averaged over five years. 
 
It is estimated that from 2005–09 around 4 270 people were treated annually at a hospital 
emergency department following a drug-related accident, violent incident or self-mutilation 
(compared with 16 000 related to alcohol). Of these cases, 46 % were aged 20–29 and 73 % were 
male. Poisoning was the most frequent cause of the emergency (75 %). The proportion of drug-
related emergencies following an accident, violent incident or self-mutilation requiring 
hospitalisation was relatively high at 36 %. From the cases in which the drug was known (63 %), 
cocaine was the most frequently cited (in 45 % of the cases). 
 
Data from the National Poison Information Centre (NVIC)  
Another source of information on trends in drug-related emergencies is provided by the number of 
intoxications about which physicians, health authorities, and others have requested information by 
telephone (and, since, 2008, via the internet) from the NVIC at the University Medical Centre 
Utrecht. These data are only indicative, however, and do not reliably represent the actual number 
of acute intoxications. 
 
The number of requests for information on acute intoxications recorded by the NVIC increased 
between 2000 and 2005 but dropped slightly in 2006. During 2008, 2009 and 2010 there were 
1 212, 1 158 and 1 243 requests respectively. In 2010 the most common request was related to 
cocaine (243 of 1 243, or 20 %), almost the same proportion as in the previous two years (255, or 
21 %, in 2008 and 238, or 21 %, in 2009). 
 
National Drug Monitor 
The four data collection systems on drug-related emergencies in the Netherlands described above 
are completed by the National Drug Monitor, administered by the Trimbos-instituut (the 
Netherlands Institute of Mental Health and Addiction). This system collects the number of clinical 
admissions in general hospitals due to drug use or dependence (as a primary or secondary 
diagnosis). Data on clinical admissions in the hospitals are from the Dutch Hospital Registration 
(LMR), which is held by the Dutch Hospital Data Foundation (DHD) and covers all hospitals in the 
Netherlands. The exact proportion of clinical admissions that has resulted from an emergency is 
not known, and some (likely to be few) admissions might not be emergencies. Nonetheless, this 
indicator is presented as it allows identification of trends in cocaine morbidity: Figure 3 shows 
clinical admissions in general hospitals due to cocaine use or dependence in the Netherlands over 
a 13 year period from 1999. 
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Figure 3 
Hospital admissions in general hospitals due to emergencies related to 
cocaine use or dependence (primary or secondary diagnosis) in the 
Netherlands, 1999–2011. 
  
Sources:  
National Drug Monitor, Trimbos-instituut (the Netherlands Institute of Mental Health and 
Addiction), Utrecht, 2011.  
Reitox National Focal Point, Netherlands (2012), National report 2011: Netherlands, 
European Monitoring Centre for Drugs and Drug Addiction, Lisbon 
(www.emcdda.europa.eu/html.cfm/index213775EN.html). 
EMCDDA (2013c), Perspectives on drugs: emergency health consequences of cocaine use in 
Europe, European Monitoring Centre for Drugs and Drug Addiction, Lisbon. 
(www.emcdda.europa.eu/topics/pods/cocaine-related-emergencies). 
 
 
 
 
Most recent data (from the 2011 National report) 
In 2011 the number of regions participating in the Monitor Drugs Incidenten (MDI) increased to 
eight and a total of 25 institutions participated. As in previous years these included ambulance 
services, emergency departments in hospitals, forensic doctors and organisations with a first aid 
medical post at dance parties. 
 
A total of 3 652 emergencies were reported, from ambulance transportation services (2 022), 
hospital emergency departments (257), forensic doctors (327) and emergency posts at dance 
parties (1 046). It is not possible to compare these statistics with those from previous years, as the 
nature and number of contributors to the MDI has changed.  
 
Similar to previous year, most patients were males. The majority were aged 25 or over, except for 
those reported from dance parties, the majority (57 %) of whom were under the age of 25. Around 
85 % or more of the cases had used a combination of drugs. Around 90 % suffered intoxication 
and the remainder suffered trauma.  
 
Similar to previous years, cocaine alone was involved in 8 % of the cases reported from both 
ambulance transportation and hospital emergency departments. Cocaine cases were rare at dance 
parties (1 %) but more frequent in forensic cases (19 %).  
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In 2011, Amsterdam ambulance transportation data reported 179 ambulance attendances to 
patients who had used cocaine, an increase on the 130 reported in 2010. More than half (55 %) of 
the cocaine-related cases in 2011 required transportation to hospital (a proxy measure for the 
seriousness of the emergency) compared with 67 % in 2010. 
 
Letsel Informatie Systeem (LIS) data are averaged over five years and, compared with the 
previous 2005–09 figures, the 2006–10 figures are stable, with an estimated 4 200 people treated 
annually at a hospital emergency department for drug-related episodes. Around 17 000 were 
treated because of alcohol use. Similar to previous estimates, around half of the patients (47 %) 
were aged 20–29 years, and three-quarters (74 %) were males. Poisoning was the most frequent 
cause of emergency (74 %). The information on the type of drug involved was available in around 
four in five cases. In these cases, cocaine was the most frequently mentioned drug (28 % of the 
cases), followed by GHB (22 %) and cannabis (18 %). The National report 2011 suggests that it is 
likely that patients underreport drug use, and thus these statistics might be an underestimate of the 
actual number of emergencies related to drug use.  
 
Data from the National Poison Information Centre (NVIC) show that, as in 2010, cocaine was 
the most frequent drug on which the NVIC was consulted. There was a small decrease in the 
number of cocaine-related calls in 2011 (219 compared with 243 in 2010).  
 
As shown in Figure 3, the National Drug Monitor reports a slight increase in 2011, with 896 cases 
admitted to the hospital with primary (86) or secondary diagnosis (800) related to cocaine. This 
compares with 870 cases in 2010. 
 
 
Romania 
 
National reports 2007–10 
In 2009 data on drug-related cases were requested from 56 emergency hospitals from the 
administrative territorial units of Romania, 15 in the Bucharest Municipality. Of these, 45 responded 
to the request (including 11 in the Bucharest Municipality) and they reported a total of 999 drug 
emergency cases. 
 
In 2010 data were requested from 70 emergency hospitals and 65 responded, reporting 2 935 non-
fatal drug-related emergency cases. However, the number of reporting hospitals changed, and no 
details were available on trends in those hospitals that had reported data in both 2009 and 2010. 
Valid comparisons between 2009 and 2010 are therefore limited. 
 
In 2010 data were reported for each of nine regions. The Bucharest-Ilfov region had the highest 
number of non-fatal drug-related emergencies, followed by the North East region. Bucharest-Ilfov 
had also reported the most cases in 2009, followed by the North West region. 
 
Almost three-quarters of the cases reported in 2010 were males (2 114 of 2 935, or 72 %) and the 
male:female ratio was 2.6. Over half (57.7 %) of the patients in drug emergency units in 2010 were 
aged 24 or younger; just over a quarter (28.1 %) were aged 25–34; and the remaining 14 % were 
aged over 35. The average age of the cases was 26 years (27 for females and 25 for males). In 
males, the predominant age group was 20–24 years (35 %) compared with 21 % of females in this 
age group. Among females, the predominant age group was 15–19 years (27 % compared with 
20 % for males). The modal value of all cases is 20 years and there is a concentration of a very 
large segment of the analysed population in the age group 15–39 years.  
 
Compared with 2009, there was an increase in the proportion of cases aged under 35 (from 72 % 
in 2009 to 87 % in 2010). While there was a small change in the age of males compared with the 
previous year (80 % were aged under 35 in 2009, compared with 89 % in 2010), there was a 
considerable increase of the proportion of females aged under 20 (12 % in 2009 and 34 % in 2010) 
and a decrease of the proportion aged over 30 (from 51 % to 30 %). The male:female ratio is 
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higher for those aged under 45. The male:female ratio is the highest (4.2 males:1 female) for the 
age group 20–24, while there are more females than males among those aged over 45 (1.3 
female:1 male).  
 
Of the 2 935 cases of drug-related emergencies reported in 2010: 
 
• 89 % (2 622) were caused by acute intoxication with a variety of licit and illicit substances. 
This represents an increase from 77 % in 2009. In 2010 the most common cases (43.6 %) 
were related to ‘ethno-botanicals’ (substances from plants), followed by acute intoxication 
with medicine (17.5 %).  
 
• 5.7 % (168) had withdrawal syndrome. This was similar to the proportion of 6 % in 2009. 
 
• 1.6 % (46) had overdosed, a significant decrease from 14 % in 2009. There were no 
registered cases of cocaine overdose in 2010, while they comprised 0.4 % of drug-related 
emergencies in 2009.  
 
• 1.4 % (41) presented with symptoms of coma, a significant decrease from 3.1 % in 2009. 
 
• 1.9 % (58) were diagnosed with emergencies related to the use of psychoactive substances 
(self-induced lesions and trauma, accidents and other external incidents), an increase from 
0.2 % in 2009. 
 
• Cocaine was involved in 0.5 % of drug-related emergencies, compared with 0.2 % in 2009.  
 
From 2009–10, there was an large increase (from 275 to 1 023) in the number of cases that were 
toxicologically tested, meaning that cases for which the diagnoses based on clinical assessment 
made by the specialist medical doctor could be confirmed or complemented by the toxicology 
findings. In 2010, half (512) of the 1 023 tests were positive for at least one substance. However, 
only 35 % of the 2 935 cases underwent toxicological tests and so in most cases a doctor had to 
establish a diagnosis based only on talking to the patient and their symptoms.  
 
Most recent data (from the 2011 National report) 
In 2011 the National Anti-drug Agency improved the process of data collection on medical 
emergencies caused by the use of psychoactive substances, by upgrading and disseminating at 
national level the methodology for monitoring non-fatal emergencies. As in 2010, however, only in 
a small part of the country was covered and data were only reported by the counties of Bucharest 
and Iaşi. 
 
In 2011 a total of 2 578 medical emergencies cases caused by psychoactive substance use were 
reported, of which 34 were excluded (31 of these cases were not specified as an emergency and 
three were caused exclusively by nicotine use). There was a 12 % decrease in the number of 
medical emergencies compared with 2010. 
 
Males accounted for 73.4 % of the cases. More than the half (55 %) of the patients were under 24 
years old, almost a quarter (25.5 %) were aged 25–34, and the rest (11.7 %) were over 35 years 
old. The average age of the cases was 25 and female patients were slightly older than males.  
 
Of the 2 578 cases, 88.4 % (2 279) were caused by acute intoxication with different substances 
(alcohol and medicines included). Of these, acute intoxications with new psychoactive substances 
(‘ethno-botanical plants’) had the highest preponderance (46.5 % compared with 42.6 % in 2010), 
followed by acute intoxications due to polydrug use (18.7 % compared with 8.8 % in 2010). The 
proportion of acute intoxications with cocaine, methamphetamine, volatile chemical solvents, 
ecstasy and toxic substances was below 1 %. Of the 15 recorded cases of overdose, 10 were 
reported as overdoses with medicines and five as opiate overdoses. 
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Toxicological tests were positive in 741 of the 1 238 cases that were tested. A single substance 
was identified in 512 cases, two substances in 137 cases, three in 49 cases, and four substances 
in 20 cases. The remainder had between five and 10 substances in their bodies.  
 
Compared with the previous years, despite the increase in the number of cases that underwent 
toxicological testing (275 in 2009; 1 023 in 2010; 1 238 in 2011), the proportion of the cases 
undergoing such testing hardly covered half of the number of cases. Thus the doctor on duty is put 
in the position to make a diagnosis based only on the medical history and the current symptoms. 
 
 
Slovenia 
 
National reports 2007–10 
The number of illicit drug poisonings is ascertained from the database of the medical emergency 
department at the University Medical Centre in Ljubljana, where diagnoses are classified according 
to the International Classification of Diseases (ICD-10) (9). However, patients treated in outpatient 
departments are classified only according to their main diagnosis, which limits the details available 
for analysis. In addition, the classification of illicit drug poisonings according to ICD-10 is reported 
to be complicated (e.g. it is sometimes difficult for the pathologists to prioritise which drug is 
responsible for their main diagnosis) and incomplete, as some substances have no specific ICD-10 
codes. 
 
In 2010 illicit drug poisonings accounted for at least 0.24 % (51) of a total of 21 700 of cases 
admitted to the medical emergency department at the University Medical Centre in Ljubljana, 
although the proportion could be higher because these diagnoses are frequently incorrectly 
classified. The mean age of the cases was 29.5 and the majority (79 %) were male. Of those 
treated for heroin poisoning, 83 % were males, whose mean age was 31.5. Cocaine was involved 
in 12 (23.5 %) cases (cocaine alone in five cases, with heroin in six, and in combination with 
alcohol in one). All 12 cases were male, with a mean age of 33.  
 
In 2009, according to data from the National Institute of Public Health (NIPH), there were 3 015 
hospitalisations due to mental and behavioural disorders related to the use of psychoactive 
substances (3 042 in 2007; 3 058 in 2008). In all three years the cause of the majority of these 
cases was related to alcohol use, followed by the simultaneous use of multiple drugs, use of 
sedatives and hypnotics, opioids, and cannabinoids. Four cases (0.1 %) were related to cocaine in 
2009, six (0.2 %) in 2008 and four (0.1 %) in 2007.  
 
Most recent data (from the 2011 National report) 
In 2011 drug poisonings accounted for 0.19 % (42) of all cases treated in medical emergency units. 
The mean age of the cases was 29 years and most were males (67 %).  
 
In 2011 the number of cocaine poisoning cases remained almost unchanged from the previous 
year (10 cases compared with 12 in 2010). 
 
 
United Kingdom  
 
 
National reports 2007–10 
In 2009 the United Kingdom National Focal Point convened a working group to discuss the 
potential use of hospital data on drug poisoning/misuse and to agree on a common case definition 
that could be applied across the United Kingdom’s constituent countries. One of the decisions 
                                               
(9) World Health Organization, International Classification of Diseases, 10th version (ICD-10) 
(www.who.int/classifications/icd/en/). 
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made was to include cases with a secondary diagnosis of drug poisoning/misuse rather than only 
those with a primary diagnosis, in order to better identify the impact of drug use on hospital 
services.  
 
In the National reports, several sources and data are mentioned: 
 
• Hospital inpatient admissions data are from individual UK countries. The data for 
England uses primary diagnosis only but provides the longest trend data, with records 
available from the end of the 1990s.  
 
• Inpatient discharge data records poisoning by drugs across the whole country. The case 
definition for these data includes secondary diagnoses, which is a relatively over-inclusive 
definition compared to that used for the long-term data in England. Therefore, no 
comparison can be made. The limitation of this source is that data have only been 
published from 2007–08 onwards, due to concerns about the comparability of previous 
data. 
 
• Data on discharges of psychiatric inpatients with a diagnosis of drug misuse are 
available from 2007–08 to 2010–11, although the 2010–11 data were not systematically 
reported on in the National report (although included in some cross-indicator analyses). 
 
Data on drug poisonings/misuse for the United Kingdom are based on hospital discharges while 
the data from England are on admissions. The effect this has on the data is unclear and further 
investigation is required. Another difference between the case definition for England and the one 
for the whole of the United Kingdom is that the latter are based on the country in which the hospital 
is located rather than the address of the patient. 
 
Detailed data based on ICD-10 codes are only available for those who are admitted to hospital as 
an inpatient (10). Research has shown that only a small proportion of those presenting to hospital 
with drug toxicity were admitted and many of these were assigned to a wide variety of codes, with 
so-called ‘recreational’ drug use often not recorded (Wood et al., 2011).  
 
Data for 2009–10 show that: 
 
• There were 30 618 inpatient discharges recording poisoning by drugs (compared with 
28 811 in 2007–08 and 31 319 in 2008–09). Almost all (99 %) of drug poisoning cases were 
emergency admissions.  
 
• Heroin was most commonly identified in drug poisoning discharges: 3 155 cases were 
recorded in 2009/10 (10.3 % of all drug poisoning discharges). Cocaine was the second 
most common, with 1 986 cases (6.5 % of discharges). This was a decrease from the 
proportion of cocaine poisonings in 2008–09 (2 627 or 8.4 % of discharges). 
 
• There were 22 271 inpatient discharges related to mental and behavioural disorders due to 
drugs (compared with 21 115 in 2007–08 and 23 065 in 2008–09). This figure excludes 
                                               
(10) Hospital activity (Hospital Episode Statistics — HES) (www.ic.nhs.uk/statistics-and-data-
collections/hospital-care/hospital-activity-hospital-episode-statistics-hes). 
Patient Episode Database Wales (www.infoandstats.wales.nhs.uk/page.cfm?orgid=869&pid=40977). 
ISD Scotland Inpatient and Day Case Activity (www.isdscotland.org/Health-Topics/Hospital-Care/Inpatient-
and-Day-Case-Activity). 
Northern Ireland Hospital Statistics (www.dhsspsni.gov.uk/index/stats_research/hospital-
stats/inpatients.htm). 
Experimental accident and emergency data are available in England but record only limited diagnosis data 
(www.hscic.gov.uk/searchcatalogue?productid=4731&q=title%3a%22accident+and+emergency+attendance
s%22&topics=0%2fHospital+care&sort=Relevance&size=10&page=1#top). 
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cases related to dependence syndrome, since these are likely to be planned inpatient 
treatment patients. Cocaine was involved in 3 502 (15.7 %) of these cases in 2009–10 
(4 403 or 19.8 % in 2008–09). 
 
Using a different case definition, Figure 4 illustrates the number of hospital admissions, with a 
primary diagnosis of cocaine poisoning (code T40.5) in England over a 13-year period from 1999. 
 
Figure 4 
Cocaine-related health problems as the primary diagnosis: inpatients 
admitted from hospital emergency settings* in England, 1999/2000–
2011/2012. 
 
*The figure does not include those with cocaine-related health problems who are discharged 
directly from the emergency department, nor those with a primary diagnosis of mental and 
behavioural disorders due to the use of cocaine. 
 
Sources: National Health Service Information Centre 
(www.hscic.gov.uk/searchcatalogue?q=title%3a%22Hospital+Episode+Statistics%2c+Admitte
d+patient+care+-+England%22&sort=Relevance&size=20&page=1#top).  
Reitox National Focal Point, United Kingdom (2012), National report 2011: United Kingdom, 
European Monitoring Centre for Drugs and Drug Addiction, Lisbon 
(www.emcdda.europa.eu/html.cfm/index214115EN.html). 
EMCDDA (2013c), Perspectives on drugs: emergency health consequences of cocaine use in 
Europe, European Monitoring Centre for Drugs and Drug Addiction, Lisbon. 
(www.emcdda.europa.eu/topics/pods/cocaine-related-emergencies). 
 
 
Most recent data (from the 2011 National report) 
In 2010–11, there were 33 889 inpatient discharges recording poisoning by drugs, almost two-
thirds of which (21 509 or 63 %) were due to ‘other opioids’ (including morphine and codeine). As 
in previous years, almost all drug poisonings were emergencies (97 %). 
 
There were 2 500 heroin poisonings. Cocaine was the next most commonly cited individual drug 
(2 247 inpatient discharges) followed by methadone (1 954 discharges). 
  
The number of inpatient discharges recording heroin poisonings was relatively stable until 2010–11 
when it decreased by 21 % from the previous year (from 3 155 in 2009–10 to 2 500 in 2010–11). In 
contrast, methadone poisonings increased by 27 % (from 1 533 in 2009–10 to 1 954 in 2010–11) 
and poisonings by other opioids increased by 12 % (from 19 266 in 2009–10 to 21 509 in 2010–
11).  
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Following an increase in cocaine poisonings between 2007–08 and 2008–09 (from 2 477 to 2 627), 
the number then decreased in 2009–10 (to 1 986). The emergence of mephedrone during the 
same period of time has been hypothesised as a possible factor in the reduction in cocaine-related 
harms. The decline in cocaine purity reported in the United Kingdom in recent years might be 
another factor in the reduction in these harms. However, cocaine poisonings increased by 13 % in 
2010–11 on the previous year (from 1 986 to 2 247), although they are still at a lower level than in 
the previous two years.  
 
In England, where longer time data are available (Figure 4), the most recent figures show a 
stabilisation of the number of cocaine poisoning admissions in the 2011/12 data (663 cases). 
 
In 2010–11 there were 27 436 inpatient discharges with a diagnosis of drug misuse in the United 
Kingdom, 15 % (4 209) of which were due to the use of cocaine. This is a higher number than in 
2009–10, but a similar proportion of all discharges. 
 
The contributory factor system enables up to six factors to be recorded for road accidents attended 
by the police. The police use a form that includes 77 contributory factors, which fall into nine 
categories. One of the nine categories for drivers is ‘impairment or distraction’, which includes the 
factor ‘impaired by drugs (illicit or medicinal)’. The ‘pedestrian only (casualty or uninjured)’ category 
contains the factor ‘pedestrian impaired by drugs (illicit or medicinal)’. In 2010 impairment by drugs 
(illicit and medicinal) was recorded as a contributory factor in 39 fatal road traffic accidents (2 % of 
the total) and 158 serious accidents (1 %). Pedestrians involved in these accidents who were 
impaired by drugs (illicit or medicinal) were a contributory factor in nine fatal accidents (1 % of the 
total) and 57 serious accidents (0.3 %).  
 
 
Norway 
 
National reports 2007–10 
According to the 2009 National report, data were collected by a survey conducted by Oslo 
University Hospital, Ullevål, and the Norwegian Institute of Public Health. This survey showed that 
around one in four drivers of cars and motorcycles who were injured in serious accidents had 
alcohol, tranquilisers and/or narcotic substances in their blood.  
 
Over a year, all patients admitted to the emergency admission department at the hospital with 
injuries resulting from road accidents were asked if they were willing to take part in the study. The 
analyses of the 132 blood samples of those who agreed showed that 34 (26 %) had amounts of 
psychoactive substances in their blood and that a third of them had a combination of two or more 
substances. The most frequently found substances (alone or in combination with other substances) 
were alcohol (50 %), diazepam (Stesolid, Valium) (30 %), zopiclone/Imovane (12 %), 
amphetamines (24 %), and cannabis (15 %). There were no reports of the presence of cocaine. 
 
There were no new nor updated data in the 2011 National report. 
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Annex 2: Data from the US Drug Abuse Warning Network (DAWN) 
 
Data from DAWN (2012) reveal that in 2010 there were nearly 4.9 million drug-related emergency 
department visits in the United States, of which almost half (47.4 % or 2.3 million) were attributed 
to adverse reactions to pharmaceuticals and almost half (46.8 % or 2.3 million) were attributed to 
drug misuse or abuse. The latter category comprised 1 346 000 cases of the misuse or abuse of 
pharmaceuticals and 1 171 000 of illicit drugs. Emergency department visits resulting from the 
misuse or abuse of pharmaceutical drugs occurred at a rate of 434.9 visits per 100 000 population, 
compared with a rate of 378.5 per 100 000 population for illicit drugs. The total number of drug-
related emergency department visits increased by 94 % from 2004 (2.5 million visits) to 2010 
(4.9 million visits). Unlike cases involving pharmaceutical drugs, the number of visits involving illicit 
drugs was generally stable during the same period, from 991 640 cases in 2004 to 1 171 000 in 
2010.  
 
In 2010 cocaine and cannabis were the most frequently used drugs of hospital emergency 
department cases involving illicit drug use. Cases related to the use of cocaine and marijuana were 
responsible for the highest number of visits, with 488 101 related to cocaine and 470 845 to 
cannabis. There were 157.8 and 152.2 visits per 100 000 population respectively for cocaine and 
for cannabis in 2010. About a quarter of the cocaine-related visits in 2010 were patients aged 20 or 
younger (23.8 %) and more than one-third were female (36 %). The rate of cocaine-related visits 
was double in males (206.0 visits per 100 000 males) compared with females (111.0 visits per 
100 000 females).  
 
There was a 15 % increase in the number of cocaine-related visits compared with the 422 896 
visits reported in 2009. In 2009 mentions of cocaine by emergency department patients had 
decreased by 12 % compared with 2008 and by 24 % compared with 2007, when a peak was 
reached with 553 530 visits related to the drug. 
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Annex 3: Relevant findings from the DRUID project 
 
We summarise below the main findings of the DRUID project (EMCDDA, 2012b), with a focus, 
where available, on the prevalence and the increased risk of a road traffic accident associated with 
cocaine. This summary provides the background against which some countries reported 
emergencies following a cocaine-related road traffic accident for the present report.  
 
The DRUID project aimed to quantify the size of the drink- and drug-driving problem in Europe, 
including alcohol, medicines and drugs. The three sources of information used are:  
 
roadside surveys, using tests positive for drugs among sampled drivers to measure the 
prevalence of the substance among the driving population; 
 
studies using positive drug tests to estimate the prevalence among the hospitalised, 
seriously injured or dead drivers; and  
 
experimental studies with measured doses of drugs given to drivers on the road or in 
simulators. 
 
Roadside surveys were conducted in 13 countries across Europe, in which blood or oral fluid 
samples from 50 000 drivers were analysed. Results revealed that alcohol was present in 3.48 % 
of cases, illicit drugs in 1.90 %, medicines in 1.36 %, combinations of drugs or medicines in 
0.39 %, and alcohol combined with drugs or medicines in 0.37 %. Cocaine was present in 0.42 % 
of the drivers with a range from 0–1.45 % depending on the countries. Drivers were considered 
positive with at least 10 ng/ml of cocaine in their blood, or 170 ng/ml in their oral fluid. 
 
Studies of hospitalised, seriously injured car drivers were conducted in six countries, and studies of 
car drivers killed in accidents took place in four. Among the injured or dead drivers, the most 
commonly consumed substance was alcohol alone, followed by alcohol combined with another 
substance. The use of illicit drugs alone was infrequently detected. 
 
After alcohol, the most frequently found substance among injured drivers was tetrahydrocannabinol 
(THC) followed by benzodiazepines, whereas among drivers killed in accidents, it was 
benzodiazepines. Cocaine (and/or benzoylecgonine, one of its metabolites) was found in 0–1.3 % 
of seriously injured car drivers. This compared to a higher prevalence for alcohol (found in 14.1–
30.2 % of the cases) and cannabis (found in 0.5–2.2 % of the cases). No cocaine was found in the 
dead drivers in the four countries in which they were tested. 
 
The relative risk of being seriously injured or killed in a traffic accident was estimated by combining 
the roadside and hospital study results in a case control study. The project assigned the 
investigated substances to one of four groups, according to whether the increased risk was 
considered to be slight, medium, high or extreme. Results showed that alcohol is one of the most 
dangerous psychoactive substances used by drivers. The highest risk for a driver of being 
seriously injured or dying in a traffic accident arises from high blood alcohol levels (>1.2 g/l) or from 
combinations of alcohol, drugs or medicines. The risk of being seriously injured or killed in a traffic 
accident for these drivers was greatly increased: it was 20–200 times higher than the risk for other 
drivers.  
 
The increase in risk for drivers who tested positive for multiple drugs, for amphetamines or for a 
blood alcohol concentration just above the common legal limit (>=0.8 g/l and <1.2 g/l) was 5–30 
times higher than for other drivers. 
 
For cocaine alone, or benzoylecgonine, there was a medium increase in the risk, estimated as 2–
10 times higher than for drivers who tested negative for this drug. Other drugs such as 
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benzodiazepines and z-drugs (a group of non-benzodiazepine drugs with effects similar to 
benzodiazepines that are used in the treatment of insomnia), illicit opioids and medicinal opioids sit 
in the same category of risk as cocaine. The risk associated with benzoylecgonine, which is not an 
active agent, might be caused by sleep deprivation after consumption of cocaine. 
 
The risk increase was 1–3 times for drivers positive for low alcohol in their blood (0.1 g/l ≤ alcohol 
in blood <0.5 g/l) and for cannabis.  
 
With regards to stimulants in general, including amphetamines, ecstasy and cocaine, the authors 
concluded, based on experimental studies, that these drugs had no negative influence on fitness to 
drive. Nonetheless, studies of drivers injured and killed in accidents found considerably higher 
median drug levels for stimulants. Such levels may have detrimental effects on self-perception, 
critical judgement and risk-taking and the authors concluded that stimulants do not compensate for 
alcohol use or sleep deprivation. 
 
The main conclusion of the report was that as the risk and share of injuries is higher for alcohol, 
the first priority of law enforcers should always be to target driving under its influence. 
